Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3042596	-koronho	— (—)	4490	7240	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Condition for Implicit Sepsis (Organ dysfunction codes)

1173

2286

3.68

323.31

1.9

1.5

—

Certain infectious and parasitic diseases

1135

1389

4.14

320.04

1.7

1.3

—

Anaemias

397

202

13.17

319.54

2.1

1.3

—

All kidney diseases

1322

2745

3.34

312.77

1.8

1.5

—

Persons encountering health services for specific procedures and health care

1405

2597

3.29

310.90

1.8

1.5

—

Other bacterial diseases

1736

2217

5.08

307.65

1.8

1.5

—

Covid-19 confirmed case

737

1538

4.95

307.65

2.1

1.5

—

Other medical care

892

1556

5.31

307.65

1.7

1.5

—

ILD, hospital admissions

587

605

10.58

307.65

2.5

1.5

—

COPD/asthma/ILD related infections

1460

982

7.58

307.65

1.7

1.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1634

2620

4.39

307.65

1.8

1.5

—

Asthma (only as main-diagnosis), excluding more controls

696

507

7.95

307.65

1.8

1.2

—

Interstitial lung disease endpoints

593

614

10.52

307.65

2.5

1.4

—

Asthma, excluding more controls

791

507

8.25

307.65

1.8

1.2

—

Agranulocytosis

396

413

10.39

307.65

2.1

1.6

—

Implicit bacterial Sepsis

826

1294

5.84

307.65

1.9

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

2197

1762

8.63

307.65

1.9

1.3

—

Lung transplant status

203

285.49

307.65

5.0

1.7

—

First line medication for Crohn's disease

1743

1810

5.30

307.65

1.9

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

529

196

20.97

307.65

2.7

1.4

—

Other diseases of blood and blood-forming organs, wide

584

845

7.28

307.65

2.0

1.5

—

1959

982

12.47

307.65

1.9

1.3

—

COPD differential diagnosis

845

588

7.29

307.65

1.7

1.2

—

Other respiratory diseases principally affecting the interstitium

655

704

10.05

307.65

2.4

1.5

—

Viral pneumonia

365

282

13.72

307.65

2.3

1.3

—

Heart failure, not strict

1161

1972

4.08

307.65

1.8

1.6

—

Bacterial Sepsis

941

1446

5.74

307.65

1.9

1.4

—

Other interstitial pulmonary diseases

593

608

10.63

307.65

2.5

1.4

—

Renal tubulo-interstitial diseases

1294

2668

3.68

307.65

1.8

1.6

—

Other pulmonary diagnosis

864

596

7.36

307.65

1.7

1.2

—

All influenza

507

549

9.57

307.65

2.0

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

1747

1972

5.05

307.65

2.0

1.3

—

Implicit viral Sepsis

525

645

8.55

307.65

2.1

1.4

—

Respiratory insufficiency

247

104

25.29

307.65

2.7

1.2

—

Asthma (mode)

734

588

6.77

307.65

1.7

1.2

—

Bronchitis

1572

2586

3.89

307.65

1.9

1.4

—

Other diseases of pleura

895

1723

4.70

307.65

2.1

1.5

—

Oral corticosteroids

1697

2272

4.52

307.65

2.0

1.3

—

Explicit Sepsis

878

1493

5.66

307.65

2.0

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2118

1879

7.92

307.65

1.8

1.4

—

Implicit Sepsis

1215

2243

4.03

307.65

1.9

1.5

—

Excluding asthma or asthma-COPD overlap

845

596

7.20

307.65

1.7

1.2

—

Other acute lower respiratory infections

1009

2143

4.60

307.65

2.0

1.5

—

All pneumoniae

2210

1775

8.58

307.65

1.9

1.4

—

General symptoms and signs

1327

1673

4.03

307.65

1.7

1.5

—

L04AA Selective immunosuppressants

641

805

8.42

307.65

2.7

1.5

—

Inflammatory bowel disease treatment related agents

1680

2352

4.06

307.65

2.0

1.3

—

Bacterial pneumoniae

604

806

6.76

307.65

2.1

1.3

—

ILD medications

1757

2012

4.82

307.65

1.9

1.3

—

Asthma

826

588

7.47

307.65

1.8

1.2

—

Asthma (only as main-diagnosis)

718

588

7.16

307.65

1.8

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

682

1005

7.17

307.65

2.0

1.5

—

ILD differential diagnosis

845

588

7.29

307.65

1.7

1.2

—

Other bacterial diseases

1799

2222

5.58

307.65

1.8

1.5

—

COPD (mode)

458

312

11.84

307.65

2.0

1.2

—

L04AD Calcineurin inhibitors

573

398

16.32

307.65

3.0

1.6

—

Nephropathy related operations

422

511

8.92

307.65

2.0

1.6

—

Viral Sepsis

525

646

8.53

307.65

2.1

1.4

—

Implicit Sepsis

1221

2105

4.47

307.65

1.8

1.5

—

Influenza and pneumonia

2203

1683

8.57

307.65

1.8

1.3

—

Asthma, unspecified (mode)

639

545

8.98

307.65

1.7

1.2

—

Transplanted organ and tissue status

600

323

21.56

307.65

3.0

1.5

—

Bacterial infection, other or unspecified

1271

1571

7.29

307.65

1.8

1.5

—

Liquid cancers, helper endpoint

873

1172

6.76

307.65

1.9

1.5

—

Bacterial infection, other or unspecified

1322

1663

6.97

307.65

1.8

1.5

—

Asthma, unspecified (mode), excluding more controls

619

471

10.00

307.65

1.7

1.2

—

Other septicaemia

767

1232

6.19

307.65

2.0

1.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

212

47.49

307.65

2.3

1.4

—

Implicit bacterial Sepsis

864

1389

5.54

307.65

1.9

1.4

—

Early onset COPD, excluding more controls

317

248

13.15

307.65

2.4

1.1

—

Dialysis, with operation codes

421

472

9.59

307.65

2.0

1.6

—

Septicaemia

858

1361

6.09

307.65

2.0

1.5

—

COPD/asthma related infections

1460

982

7.58

307.65

1.7

1.3

—

Fever of other and unknown origin

1579

1443

10.17

307.65

1.8

1.5

—

1516

2025

3.93

307.65

1.8

1.4

—

ILD, hospital admission 2, with pulmonary infections

513

147

39.57

307.65

2.6

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1959

982

12.47

307.65

1.9

1.3

—

ILD, hospital admissions 1, main diag only

524

544

10.52

307.65

2.6

1.5

—

Interstitial lung disease

593

614

10.52

307.65

2.5

1.4

—

ILD medications: immunosuppressive drugs

1264

1766

6.84

307.65

2.3

1.3

—

Acute bronchitis

828

1626

5.14

307.65

2.1

1.5

—

Renal failure

911

1783

4.66

307.65

1.8

1.5

—

Implicit viral Sepsis

611

974

6.50

307.65

2.1

1.4

—

Lung transplantation

203

279.06

307.65

5.0

1.7

—

ILD, hospital admissions 3, with pneumonia sepsis

467

170

31.46

307.65

2.6

1.2

—

Pneumonia, organism unspecified

2089

1603

9.45

307.65

1.9

1.3

—

Oxycodone

685

1257

5.06

305.36

1.8

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1298

2573

3.33

301.29

2.1

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1166

2318

3.52

299.28

1.9

1.4

—

All chronic kidney diseases

885

1808

4.09

294.49

1.8

1.6

—

Bacterial pneumonia (organism specified)

775

1629

4.42

294.21

2.1

1.4

—

Chronic kidney disease

639

1279

5.07

291.60

1.8

1.5

—

Asthma-related pneumonia

708

1596

4.56

286.74

1.9

1.5

—

Drug-induced neutropenia

291

254

12.67

286.62

2.1

1.7

—

Asthma, hospital admissions 3, pneumonia

708

1598

4.55

286.26

1.9

1.5

—

Asthma-related pneumonia or sepsis

708

1598

4.55

286.26

1.9

1.5

—

Pneumocystosis

179

42.04

284.03

2.4

1.7

—

Provisional assignment of new diseases of uncertain etiology

846

2220

3.89

278.75

2.0

1.5

—

Codes for special purposes

846

2225

3.88

277.85

2.0

1.5

—

Bacterial pneumonia, not elsewhere classified

516

766

6.05

277.06

2.2

1.3

—

Heart failure,strict

832

1422

4.23

274.04

1.7

1.6

—

Acute upper respiratory infections of multiple and unspecified sites

1014

2164

3.53

267.19

2.0

1.4

—

Diseases of the respiratory system

622

509

6.19

262.64

1.7

1.2

—

Any gastric operation

851

969

4.45

261.37

1.8

1.3

—

GASTRO-related operations

851

969

4.45

261.37

1.8

1.3

—

Non-Hodgkin lymphoma, all, including Hilmo

331

400

8.72

255.18

2.0

1.5

—

Any death

931

1865

3.65

253.94

1.8

1.6

—

Asthma-related infections

898

2580

3.47

249.58

1.8

1.6

—

Asthma, hospital admission 2, infections

898

2580

3.47

249.58

1.8

1.6

—

Aplastic and other anaemias

776

1912

3.88

249.15

1.9

1.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

952

2582

3.36

245.49

1.8

1.5

—

Idiopathic pulmonary fibrosis

278

287

10.55

243.46

3.2

1.5

—

Abnormal findings on diagnostic imaging of lung

774

2014

3.77

241.00

1.9

1.5

—

Dyspnoea

1167

2913

3.00

238.07

1.8

1.5

—

Care involving dialysis

258

248

11.21

237.20

1.8

1.6

—

Heart failure, strict

885

1784

3.57

232.89

1.7

1.6

—

Infections, IBD-co-morbidities

333

265

9.27

229.55

2.4

1.4

—

Protozoal diseases

188

115

19.55

229.23

2.5

1.7

—

Other anaemias

712

1816

3.82

225.09

1.9

1.5

—

Other and unspecified anaemias

709

1809

3.83

225.03

1.9

1.5

—

Malaise and fatigue

636

1215

4.28

224.64

1.7

1.5

—

All-cause Heart Failure

859

1752

3.53

222.54

1.7

1.6

—

Other heart diseases

603

852

4.70

219.98

1.8

1.5

—

Other diseases of the respiratory system

447

869

5.35

217.60

2.5

1.5

—

Other respiratory disorders and diseases

447

869

5.35

217.60

2.5

1.5

—

Abnormalities of breathing

1053

1964

3.15

216.44

1.8

1.5

—

Acute renal failure

441

857

5.34

214.65

1.9

1.5

—

Malignant neoplasm

1021

1936

3.16

211.96

1.7

1.6

—

Heart failure and antihypertensive medication

443

502

5.94

204.42

1.8

1.5

—

Later onset COPD, excluding more controls

265

213

9.85

199.52

1.5

1.2

—

L04AX Other immunosuppressants

766

2365

3.30

197.29

2.0

1.6

—

Second line medication for Crohn's disease

779

2434

3.26

196.70

2.0

1.6

—

Any reimbursement code in KELA

527

504

5.29

193.74

1.9

1.2

—

Malignant neoplasm, wide definition for exclusion

1008

1985

3.01

193.36

1.8

1.6

—

Kidney transplant status

211

207

11.25

192.15

1.9

2.0

—

Acute upper respiratory infections

1188

2736

2.70

191.31

1.8

1.4

—

ILD medications: azathioprine

269

364

7.64

187.78

2.3

1.4

—

Lung cancer and mesothelioma

238

216

9.65

186.93

1.7

1.2

—

637

1822

3.53

182.72

1.9

1.6

—

Other heart diseases, wide

1002

2155

2.87

179.95

1.7

1.6

—

Tramadol

865

1741

3.09

175.55

1.8

1.5

—

Extracorporeal dialysis

213

239

9.70

175.39

1.8

1.7

—

ILD-related respiratory insufficiency

156

112

15.86

173.63

3.5

1.5

—

COPD, hospital admission 2, with asthma infections

552

1257

3.86

172.16

2.0

1.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

499

1056

4.16

171.19

2.0

1.4

—

Any event in cancer register

1013

2165

2.79

170.05

1.7

1.6

—

Enlarged lymph nodes

258

375

7.08

168.70

1.8

1.5

—

Non-follicular lymphoma

262

392

7.10

168.13

1.9

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

654

1041

3.65

166.85

1.8

1.5

—

Erysipelas

751

1859

3.12

165.82

1.5

—

Secondary hypertension

181

171

10.94

165.10

1.7

1.4

—

Azathioprine

269

426

6.52

162.32

2.3

1.4

—

COPD

641

1586

3.37

162.05

2.0

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

504

1357

3.80

160.98

2.1

1.5

—

Erysipelas

623

1677

3.33

159.15

1.5

—

Certain infectious and parasitic diseases

709

1044

3.43

157.44

1.7

1.3

—

Fungal Sepsis

142

102

15.19

157.01

2.6

1.6

—

Thrombocytopenia, unspecified

215

279

8.24

156.91

2.0

1.6

—

Dental caries

424

986

4.24

155.44

2.3

1.5

—

Implicit fungal Sepsis

174

176

10.48

153.98

2.5

1.4

—

Glomerular diseases

356

767

4.81

153.68

1.7

1.6

—

All influenza (not pneumonia)

224

309

7.45

153.55

2.1

1.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

365

791

4.68

152.98

1.4

1.5

—

Persons encountering health services in other circumstances

549

1610

3.45

152.37

1.6

1.5

—

Intestinal infectious diseases

1066

3306

2.47

152.12

1.8

1.5

—

Heart failure and bmi 25plus

543

1003

3.74

150.40

1.6

—

Implicit fungal Sepsis

135

15.40

150.19

2.6

1.6

—

Viral pneumonia (unknown virus, not influenza)

192

231

8.82

148.94

2.6

1.7

—

Diarrhoea and gastroenteritis of presumed infectious origin

838

2832

2.70

148.43

1.8

1.5

—

Acute tubulo-interstitial nephritis

721

2145

2.94

148.18

1.7

1.5

—

Opioids

961

1856

2.71

148.06

1.7

1.5

—

Presence of other functional implants

720

1688

3.00

144.53

1.6

1.4

—

Secondary uncertain malignant neoplasm

246

401

6.36

144.48

1.8

1.5

—

Heart failure and coronary heart disease

603

1306

3.34

143.86

1.6

1.5

—

Other chronic obstructive pulmonary disease

598

1542

3.26

143.76

2.0

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes

189

235

8.45

142.43

2.0

1.5

—

Caries of dentine

373

857

4.34

141.72

2.3

1.5

—

Purpura and other haemorrhagic conditions

288

556

5.39

141.62

1.9

1.6

—

Coagulation defects, purpura and other haemorrhagic conditions

351

814

4.45

138.03

1.9

1.6

—

Diffuse large B-cell lymphoma, helper endpoint

138

117

12.73

137.99

2.1

1.6

—

Diffuse large B-cell lymphoma, including Hilmo

138

117

12.73

137.99

2.1

1.6

—

Diffuse large B-cell lymphoma

138

117

12.73

137.99

2.1

1.6

—

Other disorders of fluid, electrolyte and acid-base balance

467

1269

3.58

135.10

1.8

1.5

—

Polyarthropathies

824

2022

2.69

134.23

1.6

1.7

—

Atrial fibrillation and flutter

356

487

4.82

133.55

1.9

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

257

471

5.64

133.54

1.8

1.5

—

Failure and rejection of transplanted organs and tissues

25.96

133.04

3.4

1.9

—

Codeine

884

1832

2.64

131.92

1.7

1.5

—

Venous thromboembolism

669

2316

2.83

131.81

1.8

1.5

—

Solid cancers, helper endpoint

846

1899

2.66

130.54

1.6

—

Cardiovascular diseases

573

908

3.42

130.46

1.8

1.5

—

Invasive ventilation

194

276

7.45

130.44

2.0

1.7

—

Other viral diseases

424

1169

3.69

130.10

2.4

1.6

—

Cytomegalovirus infection, IBD co-morbidity

116

16.07

129.54

3.1

1.9

—

Glomerular disorders in diseases classified elsewhere

248

454

5.70

129.42

1.7

1.6

—

Cytomegaloviral disease

116

15.96

129.41

3.1

2.0

—

Chronic lower respiratory diseases

1233

2963

2.23

128.36

1.8

1.5

—

Pleural effusion

282

582

5.01

128.20

1.9

1.4

—

Non-Hodgkin lymphoma, all

135

124

11.73

128.11

2.0

1.5

—

Certain disorders involving the immune mechanism

325

756

4.43

127.31

2.1

1.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

293

383

5.39

127.24

1.7

1.4

—

Diagnoses used for exclusion with ILD

397

1081

3.76

124.96

1.9

1.5

—

Complications of surgical and medical care, not elsewhere classified

1050

3164

2.29

124.20

1.7

1.6

—

Hypertensive diseases (excluding secondary)

488

793

3.61

123.40

1.8

1.4

—

Other/unspecified cytomegaloviral diseases

105

17.46

122.04

3.1

1.8

—

Non-ischemic cardiomyopathy

417

920

3.72

121.96

1.7

1.5

—

Other viral diseases

469

1432

3.30

121.56

2.3

1.6

—

COPD, hospital admissions

600

1763

2.93

121.43

2.0

1.5

—

Pulmonary embolism

424

1236

3.50

120.28

1.9

1.5

—

COPD, early/later onset

603

1785

2.90

119.65

2.0

1.5

—

Viral infections characterized by skin and mucous membrane lesions

545

1854

2.99

119.10

2.1

1.6

—

Rare circulating lymphoid malignancy, including Hilmo

114

13.80

118.68

2.5

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

949

1969

2.43

117.22

1.7

1.5

—

Pulmonary heart disease

424

1260

3.44

116.73

1.9

1.5

—

Explicit bacterial Sepsis

187

288

6.71

116.07

1.9

1.5

—

Streptococcal septicaemia

169

237

7.42

114.62

1.9

1.6

—

Acute sinusitis

528

1652

2.99

114.51

2.0

1.4

—

Non-allergic asthma (mode), excluding more controls

169

234

7.26

113.77

2.1

1.2

—

Valvular heart disease excluding rheumatic fever

531

1259

3.09

113.40

1.7

1.6

—

Undetermined asthma, excluding more controls

130

136

9.73

111.34

1.7

1.2

—

Ischemic heart diseases

860

2150

2.43

111.29

1.9

1.5

—

Non-rheumatic valve diseases

520

1232

3.09

111.04

1.7

1.6

—

Other chronic obstructive pulmonary disease, including avohilmo

654

2069

2.65

109.59

1.9

1.5

—

Oedema, not elsewhere classified

341

899

3.80

109.54

1.8

1.4

—

Pain in throat and chest

783

1884

2.52

109.53

1.6

1.5

—

COPD-related respiratory insufficiency

233

472

5.13

108.52

2.7

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

299

295

5.13

107.05

1.8

1.3

—

Percutaneous Coronary Intervention

816

2092

2.42

105.20

2.0

1.5

—

Dialysis

130

151

9.31

104.19

1.6

1.8

—

ILD medications: pirfenidone

55.40

103.95

4.0

1.1

—

Non-allergic asthma (mode)

170

262

6.52

103.61

2.1

1.2

—

Cardiac arrhythmias

551

1245

2.90

103.18

1.8

1.4

—

Asthma (diagnoses ohter than nonallergic)

905

3421

2.21

103.01

1.8

1.6

—

COPD related to multimorbidity

519

1541

2.89

103.01

2.0

1.5

—

Coronary revascularization (ANGIO or CABG)

809

2092

2.39

102.10

2.0

1.5

—

Hard cardiovascular diseases

848

2177

2.35

101.83

1.9

1.5

—

Autoimmune diseases related-to ILD

808

3027

2.30

101.76

1.6

1.5

—

DVT of lower extremities and pulmonary embolism

519

1869

2.81

101.49

1.9

1.5

—

Autoimmune diseases excluding thyroid diseases

1046

2669

2.16

100.88

1.7

1.6

—

Neoplasms

708

1462

2.59

100.76

1.9

1.6

—

Undetermined asthma

130

155

8.53

100.68

1.7

1.2

—

Gout

400

1095

3.28

99.13

1.6

1.7

—

Persons encountering health services in other circumstances, wide

1139

2842

2.08

98.71

1.7

1.6

—

Autoimmune diseases excluding thyroid diseases, strict definition

1013

2588

2.16

98.39

1.7

1.6

—

Adjustment and management of implanted device

268

655

4.19

98.32

1.4

—

Unspecified acute lower respiratory infection

237

528

4.61

98.11

2.4

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

389

704

3.52

98.10

1.7

1.4

—

Syncope and collapse

418

1143

3.16

98.00

1.5

—

Headache

520

1490

2.81

97.49

1.7

1.5

—

Persons with potential health hazards related to communicable diseases

426

1402

3.05

97.13

1.9

1.6

—

Metabolic disorders

944

2658

2.19

97.00

1.8

1.5

—

Exposure to unspecified factor

999

3453

2.10

96.52

1.6

—

Gout, FINNGEN

400

1289

3.16

96.06

1.6

—

Multiple myeloma, including Hilmo

118

134

9.38

95.96

1.7

1.5

—

Early onset COPD

317

893

3.63

95.03

2.4

1.5

—

Complications of medical and surgical care

767

3132

2.27

95.01

1.8

1.6

—

Parasetamol

680

1346

2.58

94.92

1.7

1.5

—

Haemorrhage from respiratory passages

399

1156

3.16

94.08

1.9

1.4

—

Hernia of abdominal wall, postoperative

187

355

5.35

93.19

1.7

1.3

—

Atrial fibrillation and flutter with reimbursement

265

376

4.55

92.79

1.8

1.4

—

Intestinal infectious diseases

1117

3177

2.02

92.77

1.7

1.5

—

Cough

429

1384

2.97

92.28

1.8

1.5

—

Osteopathies and chondropathies

610

2318

2.48

92.03

1.9

1.6

—

Major coronary heart disease event

846

2303

2.24

91.71

1.9

1.5

—

Reimbursement for rheumatic diseases

602

2451

2.47

91.60

1.7

1.6

—

Lung diseases due to external agents

243

584

4.29

91.40

2.0

1.6

—

Bleeding

869

2874

2.17

91.15

1.8

1.6

—

Nausea and vomiting

353

1069

3.29

90.76

1.7

1.6

—

Emergency coronary revascularization (for ACS)

869

2431

2.19

89.99

2.0

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

987

3176

2.06

89.61

1.8

1.5

—

Immunodeficiencies

122

158

8.19

89.15

2.4

1.7

—

Other infectious diseases

164

291

5.88

88.65

1.9

1.6

—

Immunodeficiency with predominantly antibody defects

12.26

88.38

2.4

1.8

—

Viral infections characterized by skin and mucous membrane lesions

856

3484

2.12

87.86

1.9

1.6

—

193

403

4.90

86.45

2.3

1.6

—

Other infectious diseases

178

349

5.30

86.16

1.9

1.6

—

Disorders of other endocrine glands

499

1894

2.63

85.67

1.7

1.6

—

Respiratory conditions due to other external agents

13.81

85.08

2.0

1.8

—

Acute myeloid leukaemia and myelodysplastic syndromes

15.85

84.61

2.4

1.2

—

Morphin

15.44

84.58

2.2

1.4

—

Myeloid leukaemia

10.61

84.35

2.4

1.7

—

Asthma/COPD (KELA code 203)

888

2943

2.08

83.54

1.9

1.5

—

COPD, hospital admissions 1, only main diagnosis

447

1399

2.78

82.95

2.1

1.5

—

Emphysema

148

254

6.07

82.81

2.5

1.5

—

L01XE Protein kinase inhibitors

130

198

6.95

82.19

2.3

1.7

—

Other diseases of pericardium

108

134

8.51

81.73

2.0

1.7

—

Codeine or tramadol medication

1035

2888

1.97

79.67

1.7

1.5

—

Pericarditis

10.58

79.43

1.7

1.8

—

Pneumonia due to Streptococcus pneumoniae

12.10

78.67

1.8

1.5

—

Unspecified kidney failure

172

354

5.02

78.62

1.6

1.5

—

Care involving use of rehabilitation procedures

583

2299

2.35

78.48

1.8

1.6

—

Pain, not elsewhere classified

256

709

3.66

78.45

1.9

1.4

—

Viral pneumonia (known virus, not influenza)

10.75

78.32

2.7

1.8

—

Multiple myeloma and malignant plasma cell neoplasms

121

183

7.02

77.07

1.8

1.7

—

Other viral diseases, not elsewhere classified

263

752

3.56

76.77

2.3

1.6

—

Hypo-osmolality and hyponatraemia

253

705

3.65

76.46

1.7

1.5

—

Allergic asthma (mode), excluding more controls

145

255

5.61

76.02

1.7

1.2

—

Other bacterial intestinal infections

249

703

3.62

74.49

2.0

1.5

—

Depression medications

198

189

5.31

73.62

1.6

1.3

—

Disorders resulting from impaired renal tubular function

106

148

7.69

72.83

2.1

1.7

—

Autoimmune diseases

1017

2693

1.93

72.45

1.6

—

Conduction disorders

317

830

3.14

72.22

1.6

1.5

—

Contact with and exposure to communicable diseases

322

1080

3.01

71.82

1.8

1.6

—

Obesity related asthma

376

1380

2.76

71.73

1.8

1.5

—

Volume depletion

170

377

4.65

71.05

1.7

1.5

—

Zoster [herpes zoster]

253

749

3.45

70.42

2.0

1.5

—

Hypertensive diseases

695

1810

2.18

70.19

1.7

1.6

—

Hypertension

694

1809

2.18

69.91

1.7

1.6

—

Bronchiectasis

137

260

5.46

68.84

2.0

1.5

—

Secondary right heart disease

130

7.87

68.82

2.9

1.5

—

Lymphoid leukaemia

131

241

5.72

68.41

2.3

1.7

—

Complications of procedures, not elsewhere classified

746

3064

2.03

68.23

1.6

—

Antihypertensive medication - note that there are other indications

506

1079

2.50

67.88

2.0

1.4

—

Allergic asthma (mode)

145

283

5.06

67.81

1.7

1.2

—

Osteoporosis

313

996

2.99

67.72

1.9

1.5

—

Paroxysmal tachycardia

212

461

3.90

67.72

1.7

1.5

—

Cerebrovascular diseases (FINNGEN)

260

532

3.49

67.52

1.7

1.4

—

Other dialysis

128

8.01

67.45

1.6

2.0

—

Hypertension, essential

661

1720

2.19

67.41

1.7

1.6

—

Myocarditis

9.94

67.41

1.4

1.3

—

Hypothyroidism (congenital or acquired)

174

190

5.21

67.36

1.5

1.3

—

Enterocolitis due to Clostridium difficile

177

427

4.27

66.40

2.0

1.6

—

Hypothyroidism, levothyroxine purchases

172

189

5.19

66.27

1.5

1.3

—

Hypothyroidism and >3 levothyroxin purchases

172

189

5.19

66.27

1.5

1.3

—

Other viral diseases, not elsewhere classified

304

1033

2.97

66.24

2.2

1.6

—

Other pulmonary heart/vessel disease

103

155

6.99

65.81

2.8

1.5

—

Insulin medication

624

2477

2.14

65.64

1.7

1.6

—

Systemic connective tissue disorders

382

1480

2.62

65.52

1.7

1.5

—

Asthma, hospital admissions , main diagnosis only

767

3470

1.96

64.73

1.8

1.6

—

Adrenocortical insufficiency

119

8.01

64.67

1.8

—

Bacterial intestinal infections, IBD co-morbidities

246

755

3.32

64.65

2.0

1.5

—

Asthma, including avohilmo

1067

3323

1.81

64.40

1.7

1.6

—

Symptoms and signs involving the digestive system and abdomen

915

2397

1.92

64.25

1.7

1.6

—

Hyperkalaemia

113

194

6.06

63.29

1.9

1.4

—

Coronary atherosclerosis

588

1699

2.21

62.92

1.7

1.5

—

Gout, unspecified

277

928

3.05

62.86

1.6

—

Used for control exclusion in common control thyroid runs

936

2514

1.89

62.72

1.6

—

Other bacterial intestinal infections

267

877

3.09

62.53

2.0

1.5

—

Other pleural conditions

157

365

4.42

61.83

2.0

1.4

—

Myelodysplastic syndrome, including Hilmo

10.17

61.55

1.7

1.4

—

Infections of the skin and subcutaneous tissue

576

2710

2.12

61.45

1.8

1.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

624

2778

2.07

61.37

1.7

1.6

—

Acute myeloid leukaemia, helper endpoint

21.29

60.59

2.9

1.2

—

Acute myeloid leukaemia

21.29

60.59

2.9

1.2

—

Acute myeloid leukaemia, including Hilmo

21.29

60.59

2.9

1.2

—

Convulsions, not elsewhere classified

214

617

3.46

60.44

2.1

1.5

—

Diseases of arteries, arterioles and capillaries

663

2417

2.04

60.37

1.6

—

Infection due to other mycobacteria

16.04

60.33

2.3

1.3

—

Glomerulonephritis

166

411

4.16

60.25

1.6

1.8

—

Other disorders of adrenal gland

157

6.61

60.16

1.9

1.8

—

Mycoses

305

1103

2.81

60.04

2.2

1.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

578

2750

2.09

59.32

1.8

1.6

—

Hypoplasia of dental enamel

12.27

59.20

2.9

1.8

—

Other and unspecified immunodeficiencies with predominantly antibody defects

14.75

58.95

2.3

1.8

—

Zoster [herpes zoster]

481

2131

2.24

58.83

1.9

1.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

948

2827

1.83

58.78

1.8

1.6

—

Diseases of the skin and subcutaneous tissue

876

2337

1.89

58.56

1.8

1.5

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

10.48

58.36

1.7

1.6

—

Multiple myeloma

10.48

58.36

1.7

1.6

—

Myocardial infarction

464

1409

2.34

58.23

1.6

1.5

—

Mantle cell lymphoma, including Hilmo

15.05

57.87

1.7

1.6

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

204

599

3.47

57.54

1.5

—

Pacemaker

379

1487

2.48

57.51

1.5

—

Iron deficiency anaemia

439

1899

2.30

57.07

1.8

1.5

—

Gout, idiopatic and unspecified

313

1181

2.70

56.88

1.6

—

Other disorders of white blood cells

106

190

5.82

56.82

2.0

1.7

—

Other diseases of intestines

937

2959

1.81

56.59

1.7

1.6

—

Endocarditis

8.52

56.37

1.9

1.6

—

Molar incisor enamel hypoplasia, with caries

16.33

56.28

3.2

1.9

—

Finngen Rheumatological endpoints

818

2484

1.88

55.88

1.6

—

Gastrointestinal diseases

488

1054

2.33

55.75

1.8

1.3

—

Hodgkin lymphoma, hilmo

8.61

55.66

2.1

1.6

—

Abdominal and pelvic pain

879

2393

1.86

55.57

1.7

1.6

—

Other CVD (FINNGEN)

129

200

5.09

55.54

2.0

1.4

—

Nutritional anaemias

492

2206

2.17

55.27

1.8

1.5

—

Other arrhythmias

498

1721

2.20

55.17

1.6

—

Chronic lymphocytic leukaemia, helper endpoint

9.58

54.76

1.8

1.7

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

9.58

54.76

1.8

1.7

—

Chronic lymphocytic leukaemia

9.58

54.76

1.8

1.7

—

Other disorders of skin and subcutaneous tissue

644

2942

1.96

54.22

1.7

1.6

—

Malignant neoplasm of bronchus and lung, including Hilmo

231

619

3.17

54.09

1.7

1.5

—

Malignant neoplasm of respiratory system and intrathoracic organs

226

596

3.20

53.75

1.6

1.5

—

Cardiomyopathy

193

572

3.43

53.65

1.5

—

Other disorders of urethra and urinary system

620

2249

2.00

53.45

1.7

1.6

—

Diseases of oesophagus, stomach and duodenum

926

3138

1.77

52.97

2.0

1.5

—

Cardiodefibrillation

397

1727

2.33

52.77

1.7

1.6

—

Benzodiazepine use

871

3378

1.79

52.39

1.6

—

Insulin, fast-acting

377

1623

2.35

51.48

1.7

1.6

—

Respiratory disorders in diseases classified elsewhere

13.09

51.34

2.5

1.7

—

Gout, strict definition

236

812

2.97

51.19

1.5

1.6

—

Sleep apnoea

815

2928

1.81

50.91

1.7

1.6

—

Neurological diseases, wide definition

262

427

3.10

50.73

1.8

1.4

—

Ischaemic heart disease, wide definition

676

2184

1.93

50.70

1.7

1.6

—

Major coronary heart disease event excluding revascularizations

542

1754

2.08

50.46

1.6

1.5

—

Herpesviral [herpes simplex] infections

151

399

3.87

50.00

2.2

1.6

—

Drug-induced adrenocortical insufficiency

9.60

49.14

2.0

1.8

—

Constipation

802

3115

1.79

49.02

1.7

1.6

—

Acute drug-induced interstitial lung disorder

18.37

48.76

1.8

1.3

—

Fall on same level

975

3119

1.72

48.67

1.6

—

Extreme obesity with alveolar hypoventilation

140

6.28

48.64

1.8

1.7

—

Mantle cell lymphoma

17.96

48.61

1.7

1.3

—

Other disorders involving the immune mechanism, not elsewhere classified

121

6.83

48.58

2.2

1.9

—

Non-small cell lung cancer, including Hilmo

175

486

3.45

48.38

1.6

1.5

—

Disorders of mineral metabolism

126

300

4.32

48.22

1.7

1.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

132

326

4.16

48.09

1.6

1.7

—

Endocrine, nutritional and metabolic diseases

648

1687

1.96

48.07

1.8

1.5

—

Other complications of surgical and medical care, not elsewhere classified

132

326

4.15

48.05

1.7

1.6

—

Dermatitis

556

2847

1.96

47.91

1.7

1.6

—

AV-block

193

527

3.26

47.89

1.6

1.5

—

Insulin, fast-acting or short human

380

1697

2.26

47.64

1.7

1.6

—

Diseases of the digestive system

461

2213

2.09

47.50

1.6

—

Asthma and opportunity respiratory infection

157

5.85

47.48

2.2

1.6

—

Hypothyroidism, drug reimbursement

109

6.14

47.31

1.7

1.3

—

Other and unspecified iron deficiency

344

1480

2.35

47.10

1.8

1.5

—

Type 2 diabetes, wide definition

692

2396

1.86

46.88

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

830

3058

1.75

45.88

1.6

—

Candidiasis

165

491

3.43

45.73

2.3

1.5

—

Genitourinary diseases

522

1265

2.08

45.69

1.8

1.6

—

Haemorrhage, not elsewhere classified

8.39

45.50

1.5

1.7

—

Vocal cord dysfunction

131

294

4.05

45.22

1.9

1.4

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

108

6.95

45.06

2.3

2.0

—

Other diseases of urinary system

853

2777

1.74

44.74

1.7

1.6

—

Other diseases of the digestive system

345

1526

2.29

44.40

1.5

—

Pain in limb

718

2685

1.80

44.22

1.8

1.6

—

Other necrotizing vasculopathies

116

278

4.31

44.13

1.7

1.6

—

GI-bleeding

345

1531

2.28

44.05

1.6

1.5

—

Dermatitis due to substances taken internally

172

5.34

43.92

2.1

1.7

—

Other and unspecified dermatitis

467

2332

2.02

43.83

1.7

1.6

—

Rheumatoid arthritis

313

1188

2.39

43.63

1.6

—

Other soft tissue disorders, not elsewhere classified

814

2760

1.74

43.34

1.7

1.6

—

Other and unspecified drugs and medicaments

126

325

3.98

43.33

1.6

1.7

—

Disorders of gallbladder, biliary tract and pancreas

839

3101

1.72

43.31

1.6

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

164

5.49

43.26

2.2

1.7

—

Ulcer of lower limb, not elsewhere classified

186

616

3.08

43.26

1.4

1.6

—

Sleep apnoea, including avohilmo

827

2993

1.72

43.01

1.7

1.6

—

Noninfective enteritis and colitis

432

2110

2.06

42.96

1.7

1.6

—

Other or ill-defined heart diseases

140

5.80

42.75

1.5

1.9

—

Non-invasive ventilation

193

576

3.02

42.73

2.4

1.3

—

Other arthritis (FG)

290

1210

2.42

42.67

1.6

—

Use of hypnotics and sedatives

890

3046

1.69

42.33

1.7

1.6

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

301

793

2.48

42.18

1.4

1.5

—

Malignant neoplasm of breast, including Hilmo

301

793

2.48

42.17

1.4

1.5

—

Acute pharyngitis

142

400

3.57

42.11

1.7

1.4

—

Other general symptoms and signs

101

6.74

42.01

1.6

1.5

—

Other metabolic disorders

148

434

3.47

41.98

2.5

1.6

—

Other necrotizing vasculopathies (FG)

210

4.77

41.97

1.9

1.6

—

Suppurative and necrotic conditions of lower respiratory tract

219

4.69

41.78

2.0

1.8

—

Malignant neoplasm of breast, HER2-negative

294

779

2.49

41.74

1.4

1.5

—

Malignant neoplasm of breast

296

785

2.48

41.64

1.4

1.5

—

Chronic nephritic syndrome

145

5.69

41.42

1.7

—

Insulin, intermediate and long-acting

510

2599

1.92

41.33

1.5

1.6

—

Disorders of lens

585

1950

1.89

41.13

2.0

1.6

—

Methotrexate

131

359

3.70

41.11

1.5

1.3

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

136

5.78

40.82

1.8

1.5

—

Other disorders of kidney and ureter

168

543

3.16

40.80

2.1

1.6

—

Disorders of parathyroid gland

214

779

2.75

40.73

1.5

1.6

—

Atypical mycobacterium lung infection

11.82

40.59

2.6

1.6

—

Other reaction to severe stress, and adjustment disorders

305

1331

2.31

40.49

1.9

1.6

—

Childhood asthma (age<16), excluding more controls

106

5.92

40.37

1.9

1.2

—

Osteonecrosis

213

4.65

40.32

2.2

1.7

—

Intracranial trauma

483

1731

1.97

39.96

1.5

1.6

—

Acute lymphocytic leukaemia

16.02

39.85

3.2

2.1

—

Acute lymphocytic leukaemia, helper endpoint

16.02

39.85

3.2

2.1

—

Acute lymphocytic leukaemia, including Hilmo

16.02

39.85

3.2

2.1

—

Diabetic nephropathy, excluding more controls

182

502

3.04

39.54

1.6

1.7

—

Childhood asthma (age<16)

114

5.58

38.55

2.0

1.2

—

Myocardial infarction, strict

394

1352

2.09

38.20

1.6

1.5

—

Exclusions for E4_PCOS_BROAD

200

739

2.75

38.00

1.9

1.7

—

Adult respiratory distress syndrome

10.62

37.95

2.2

1.5

—

Seropositive rheumatoid arthritis

237

952

2.51

37.63

1.6

1.5

—

Cutaneous abscess, furuncle and carbuncle

249

1030

2.45

37.45

1.7

1.6

—

Other and unspecified disorders of white blood cells

144

5.42

37.43

2.0

1.7

—

Persons encountering health services for specific procedures, not carried out

217

4.42

37.43

2.1

1.6

—

Fentanyl

118

322

3.72

37.27

1.5

1.4

—

Rheumatoid arthritis, including avohilmo

344

1633

2.13

37.20

1.5

—

Chronic apical periodontitis

891

3136

1.63

36.91

1.7

1.6

—

Sulfasalazine

217

847

2.58

36.86

1.5

1.3

—

Factors influencing health status and contact with health services

246

470

2.64

36.44

1.9

1.3

—

7.13

36.43

2.4

1.6

—

Acute generalized exanthematous pustulosis

148

5.25

36.25

2.0

1.7

—

Sequelae of external causes of morbidity and mortality

259

1108

2.37

36.19

1.8

1.6

—

Viral and other specified intestinal infections

239

947

2.46

36.19

1.8

1.6

—

Malignant neoplasm of bronchus and lung

182

533

2.87

36.14

1.6

1.5

—

Disorders of calcium metabolism

224

4.32

36.06

1.8

1.5

—

Dependence on enabling machines and devices, not elsewhere classified

10.00

36.05

2.0

1.7

—

Concussion

415

1717

1.98

36.03

1.5

1.6

—

Pneumothorax

241

4.17

36.03

2.4

1.5

—

Nephrotic syndrome

135

5.53

35.94

1.6

1.8

—

Symptoms and signs involving the urinary system

657

2924

1.72

35.82

1.7

1.6

—

Sequelae with surgical and medical care as external cause

216

856

2.56

35.73

1.8

1.6

—

Dermatitis and eczema

902

3512

1.60

35.63

1.7

1.6

—

Phlebitis and thrombophlebitis (not including DVT)

221

886

2.53

35.62

1.7

1.5

—

Generalized skin eruption due to drugs and medicaments

132

5.51

35.62

2.1

1.8

—

Diabetes, varying definitions

809

2894

1.65

35.51

1.6

—

Dysphagia

235

971

2.45

35.47

1.8

1.5

—

Follicular lymphoma, hilmo

155

5.10

35.45

2.0

1.9

—

Other specified/unspecified arthritis

255

1095

2.35

35.29

1.7

1.6

—

Candidiasis

259

1120

2.34

35.27

2.0

1.5

—

Valvular operations

150

497

3.06

34.88

1.5

1.6

—

Anaemia in chronic diseases classified elsewhere

6.91

34.80

1.9

1.7

—

Angina pectoris

449

1558

1.93

34.68

1.6

1.5

—

Other antidepressants

838

2640

1.63

34.61

1.6

—

Other noninfective gastroenteritis and colitis

250

1076

2.35

34.40

1.8

1.6

—

Symptoms and signs concerning food and fluid intake

253

3.97

34.33

2.1

1.5

—

ILD medications: nintedanib

90.72

34.22

3.4

1.0

—

Later onset COPD

288

1041

2.23

33.52

1.5

1.4

—

Diabetes mellitus

804

2906

1.62

33.51

1.6

—

Aspergillosis

12.22

33.48

3.1

1.6

—

Kela reimbursement Agammaglobulinemia (D80-84)

12.60

33.24

2.7

1.7

—

Other and unspecified tonsillitis

239

849

2.38

33.05

1.8

1.5

—

Molar incisor enamel hypoplasia

169

4.71

32.98

2.8

1.7

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

486

2701

1.81

32.92

1.7

1.6

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

108

304

3.64

32.84

2.0

1.6

—

Other systemic involvement of connective tissue (FG)

227

943

2.40

32.82

1.7

1.5

—

Falls/tendency to fall

864

2714

1.60

32.80

1.5

1.6

—

Other functional intestinal disorders

404

1966

1.92

32.63

1.8

1.5

—

Other problems related to primary support group, including family circumstances

130

401

3.21

32.43

2.4

1.7

—

Hyperparathyroidism

181

684

2.65

32.18

1.4

1.5

—

Other external causes of accidental injury

657

1932

1.71

32.18

1.6

—

STROKE

406

1427

1.95

32.17

1.6

1.5

—

Diseases of liver

315

1532

2.08

32.05

1.6

—

Pain (limb, back, neck, head abdominally)

608

1752

1.75

32.00

1.7

1.5

—

External causes of morbidity and mortality

523

1440

1.83

31.99

1.7

1.6

—

Myocardial infarction, without ST-elevation

382

1805

1.95

31.91

1.6

—

Other or unspecified ileus, impaction or obstruction

192

760

2.56

31.84

1.8

1.5

—

Nonhereditary hypogammaglobulinemia

11.53

31.75

2.7

1.7

—

Continuous positive airway pressure

164

496

2.81

31.67

2.1

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

192

737

2.56

31.65

1.8

—

Wegener granulomatosis

8.76

31.60

2.0

1.7

—

Leukaemia of unspecified cell type

12.07

31.58

2.3

1.3

—

Cardiomyopathy (excluding other)

128

411

3.16

31.47

1.5

1.6

—

Cardiomyopathies, Primary/intrinsic

126

401

3.19

31.45

1.5

1.6

—

Viral and other specified intestinal infections

189

727

2.56

31.45

1.9

1.6

—

Abnormalities of heart beat

263

1176

2.21

31.40

1.7

1.4

—

Asthma and allergy, excluding more controls

144

4.83

31.39

1.6

1.2

—

Type 2 diabetes

754

2726

1.62

31.37

1.6

—

Cellulitis

217

920

2.39

31.04

1.8

1.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

123

390

3.22

30.99

2.4

1.6

—

Collagenous colitis

111

333

3.40

30.59

1.8

1.6

—

Malignant neoplasm of digestive organs

297

1117

2.12

30.49

1.5

—

Peripheral artery disease

402

1701

1.90

30.43

1.5

—

Gingival hyperplasia

144

4.92

30.41

2.1

—

Abnormal findings on examination of blood, without diagnosis

434

2193

1.83

30.18

1.9

1.6

—

Diabetic nephropathy

183

720

2.55

29.99

1.6

1.7

—

Senile cataract

506

1757

1.78

29.50

1.9

1.6

—

Other cataract

373

1474

1.93

29.49

1.9

1.5

—

Non-small cell lung cancer

105

309

3.43

29.35

1.5

1.4

—

Abscess of lung

7.72

29.19

2.1

1.8

—

Disorders of thyroid, IBD co-morbidities

128

285

3.18

29.16

1.5

1.4

—

Episodal and paroxysmal disorders

865

2846

1.55

29.08

1.6

—

Low back pain

599

2588

1.67

29.05

1.7

1.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

234

1055

2.24

29.00

1.6

—

Asthma and allergy

154

4.52

28.96

1.6

1.2

—

Hypoplasia of dental enamel , including avohilmo

157

4.58

28.82

2.9

1.7

—

Amputation

123

407

3.08

28.82

1.4

1.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

193

778

2.44

28.80

1.8

—

Other disorders of bladder

137

482

2.89

28.78

1.6

—

Accidents

640

1932

1.67

28.56

1.7

1.6

—

Substance abuse, excluding more controls

448

2151

1.79

28.47

1.6

—

Neurological diseases

672

2063

1.64

28.47

1.8

1.6

—

Acute laryngitis and tracheitis

283

3.48

28.45

1.8

1.4

—

Other/unspecified seropositive rheumatoid arthritis

236

1079

2.21

28.28

1.6

1.5

—

Budesonide

115

371

3.14

28.06

1.8

1.3

—

Seropositive rheumatoid arthritis, wide

237

1090

2.20

27.99

1.6

—

Paralytic ileus and intestinal obstruction

242

1123

2.18

27.88

1.7

1.5

—

Cardiomyopathy, other and unspecified

241

3.72

27.88

1.3

1.7

—

Hypokalaemia

127

436

2.96

27.88

1.8

1.5

—

Anxiety disorders, excluding more controls

619

2463

1.64

27.69

1.8

1.6

—

Injuries to the head

871

3539

1.52

27.62

1.5

1.6

—

Viral warts

106

333

3.24

27.13

2.5

1.6

—

Artificial opening status

183

4.15

27.12

2.0

1.5

—

Sarcoidosis

142

527

2.74

26.98

1.9

1.7

—

Hydronephrosis

114

375

3.09

26.98

1.8

1.5

—

Peripheral artery operations in Hilmo

139

512

2.75

26.75

1.4

1.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

114

377

3.07

26.71

2.0

1.5

—

Any mental disorder

858

2825

1.53

26.70

1.6

—

Pneumonia due to Haemophilus influenzae

63.46

26.52

2.3

1.2

—

Preparatory care for dialysis

165

4.32

26.51

1.2

1.8

—

Nonischemic cardiomyopathy

110

358

3.12

26.51

1.6

1.7

—

Pneumonitis due to solids and liquids

102

318

3.27

26.48

1.7

1.6

—

Secondary thrombocytopenia

8.89

26.46

2.1

1.7

—

Amputation of toe

289

3.40

26.43

1.5

1.7

—

Intestinal stricture

283

1423

2.01

26.39

1.7

1.6

—

Malnutrition

5.61

26.20

1.7

1.8

—

Urticaria and erythema

298

1529

1.96

26.17

1.8

1.6

—

Hypercalcemia

154

4.43

26.17

2.0

1.6

—

Endocrine disorders, other/unspecified

7.29

26.09

1.5

—

Myelodysplastic syndrome

10.69

25.89

1.6

1.3

—

Cystitis

642

2386

1.61

25.88

1.5

1.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

223

1021

2.18

25.79

2.0

1.6

—

Other nutritional deficiencies

497

2804

1.68

25.74

1.7

1.6

—

Abnormal spermatozoa

145

558

2.65

25.73

1.5

1.7

—

Hyperlipidaemia, other/unspecified

334

1641

1.89

25.73

1.6

1.5

—

5-aminosalicylic acid

146

562

2.62

25.70

1.8

1.3

—

Protein-energy malnutrition of moderate and mild degree

8.71

25.61

1.7

—

Other ill-defined and unspecified causes of mortality

102

325

3.21

25.60

1.7

1.6

—

Retention of urine

315

1348

1.93

25.54

1.5

1.6

—

Drug-induced cataract

5.86

25.46

3.4

1.8

—

Other CVD

201

901

2.26

25.37

1.8

1.5

—

Acute bronchiolitis

237

3.50

25.23

2.1

1.8

—

Herpesviral [herpes simplex] infections

196

871

2.27

25.21

2.0

1.5

—

Chronic sinusitis

340

1843

1.86

25.19

2.0

1.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

711

2766

1.55

25.05

1.5

1.6

—

Abnormal results of function studies

310

3.22

24.86

2.0

1.6

—

Other endocrine disorders

264

3.40

24.63

1.8

1.9

—

Other systemic involvement of connective tissue

232

1116

2.10

24.47

1.7

1.5

—

Ill-defined and unknown causes of mortality

108

366

3.01

24.39

1.7

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

337

1224

1.88

24.24

1.7

1.5

—

Type 2 diabetes, definitions combined

692

2626

1.55

24.17

1.6

—

IgA nephropathy (IgA glomerulonephritis)

5.88

24.02

1.6

2.1

—

Diseases of the eye and adnexa

600

1865

1.62

24.01

1.8

1.6

—

Injuries to the thorax

383

2185

1.76

24.01

1.7

1.6

—

Congenital malformations, deformations and chromosomal abnormalities

432

2425

1.70

23.89

1.9

1.6

—

Acute pancreatitis

187

836

2.26

23.79

1.5

1.6

—

Other embolism and thrombosis

132

504

2.66

23.77

1.6

—

Intracranial injury

473

2705

1.66

23.75

1.4

1.6

—

Osteoporosis with pathological fracture (FG)

220

3.62

23.73

1.9

1.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

363

1604

1.81

23.67

1.5

—

Malignant neoplasm of breast, ER-positive, including Hilmo

201

700

2.23

23.59

1.4

1.5

—

Malignant neoplasm of breast, HER-positive

198

697

2.23

23.31

1.4

1.5

—

Acquired haemolytic anaemia

5.81

23.22

2.2

1.7

—

Peripheral arterial reconstruction

173

759

2.31

23.06

1.6

1.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

315

1153

1.88

22.96

1.6

1.5

—

Marginal zone B-cell lymphoma, including Hilmo

7.55

22.69

1.8

—

Anxiety disorders

653

2968

1.54

22.68

1.8

1.6

—

Neurotic, stress-related and somatoform disorders

647

2951

1.54

22.54

1.8

1.6

—

Type 2 diabetes, strict (exclude DM1)

694

2678

1.53

22.54

1.6

—

Drug-induced osteoporosis with pathological fracture

6.79

22.44

2.5

1.7

—

Malignant neoplasm of skin

336

1266

1.83

22.34

1.6

—

Gastro-oesophageal reflux disease

522

2826

1.60

22.29

1.9

1.5

—

Diabetes, insulin treatment (Kela reimbursement)

757

3073

1.49

22.26

1.6

—

Pleural plaque

105

370

2.89

22.12

1.7

1.4

—

Mental and behavioural disorders due to psychoactive substance use

471

2684

1.63

22.10

1.6

—

Diseases of the musculoskeletal system and connective tissue

418

1208

1.74

22.09

1.7

1.6

—

Eosinophilic disease (BM)

23.28

21.91

1.7

1.3

—

Arthropathies in other diseases classified elsewhere

112

4.68

21.83

1.6

1.7

—

Malignant neoplasm of head and neck

233

3.40

21.72

1.4

1.6

—

Sleep disorders (combined)

844

3042

1.46

21.64

1.6

—

Acute pancreatitis (for exclusion)

187

870

2.17

21.62

1.5

1.6

—

Malignant neoplasm of mesothelium and soft tissue

105

4.79

21.59

1.7

1.6

—

Mood disorders, excluding more controls

681

2689

1.52

21.56

1.7

1.6

—

Haemolytic anaemias

130

4.37

21.51

2.3

1.8

—

Polyneuropathies and other disorders of the peripheral nervous system

205

992

2.09

21.41

1.9

1.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

153

659

2.35

21.32

1.7

1.5

—

Unspecified haematuria

363

1737

1.74

21.32

1.7

1.6

—

Simple and mucopurulent chronic bronchitis

148

4.09

21.28

1.9

1.7

—

Diseases of pulp and periapical tissues, including avohilmo

795

2803

1.47

21.28

1.6

—

Presence of cardiac and vascular implants and grafts

339

1418

1.79

21.27

1.5

1.4

—

Other abnormalities of plasma proteins

6.59

21.24

2.3

1.8

—

Inflammatory bowel disease

250

1301

1.94

21.20

1.7

1.6

—

Viral hepatitis, IBD co-morbidity

4.81

21.05

1.4

—

Osteopathy in diseases classified elsewhere

9.51

21.02

1.3

1.7

—

Injury, poisoning and certain other consequences of external causes

403

1170

1.73

20.97

1.7

1.6

—

Disorders of eyelid, lacrimal system and orbit

647

3268

1.51

20.89

1.7

1.6

—

Hypotension

169

767

2.23

20.82

1.9

1.5

—

Obesity

451

2699

1.62

20.60

1.6

—

L01XX Other antineoplastic agents

222

3.41

20.59

1.7

—

Spondylosis

429

2130

1.65

20.56

1.6

—

Lower back pain or/and sciatica

771

3465

1.46

20.46

1.6

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

310

2.98

20.38

1.5

—

Type 2 diabetes, definitions combined, including avohilmo

682

2661

1.50

20.26

1.6

—

Hypertensive heart and/or renal disease

216

795

2.04

20.25

1.4

1.6

—

Calcific aortic valvular stenosis, including rheumatic fever

270

1416

1.86

20.22

1.5

—

Obesity and other hyperalimentation

451

2714

1.61

20.03

1.6

—

Pneumonia derived septicemia

116

4.44

20.02

2.0

1.7

—

Any operation in hilmo

33.03

19.95

1.5

1.0

—

Calcific aortic valvular stenosis, operated

269

1419

1.85

19.86

1.5

—

Calcific aortic valvular stenosis

269

1419

1.85

19.86

1.5

—

Operations 2 for CAVS

268

1412

1.86

19.86

1.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

268

1412

1.86

19.86

1.5

—

Diseases of pulp and periapical tissues and dental caries

533

1730

1.59

19.85

1.7

1.5

—

Mycoses

627

3661

1.49

19.79

1.9

1.6

—

Seropositive rheumatoid arthritis, strict definition

133

557

2.42

19.79

1.6

—

Acute peritonitis

243

3.23

19.73

1.7

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

444

2217

1.61

19.36

1.6

—

Diabetes medication

748

3059

1.45

19.32

1.6

—

Substance abuse

448

2649

1.60

19.27

1.6

—

Unspecified fall

405

2456

1.63

19.23

1.5

1.6

—

Hypothyroidism, strict autoimmune

495

2071

1.58

19.12

1.5

1.6

—

Presbycusis

138

592

2.34

19.02

1.5

1.4

—

Pyothorax

161

3.76

18.98

2.3

1.8

—

Other and unspecified aplastic anaemias

8.51

18.95

2.2

1.4

—

Congenital malformations of the circulatory system

150

654

2.25

18.88

2.0

1.8

—

Other/unspecified rheumatoid arthritis

119

485

2.49

18.83

1.6

1.5

—

Chronic pancreatitis

122

504

2.45

18.76

1.9

1.6

—

Dorsalgia

724

2666

1.46

18.65

1.6

—

Biological medication for rheuma

142

629

2.28

18.59

1.4

1.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

197

3.40

18.47

1.9

1.5

—

Congenital malformations, deformations and chromosomal abnormalities

452

2651

1.58

18.45

1.9

1.6

—

Non-small cell lung cancer, adenocarcinoma

178

3.55

18.45

1.6

1.5

—

Dental operations

487

1582

1.59

18.35

1.7

1.4

—

Cystic kidney disease

116

4.27

18.28

1.9

—

Lack of expected normal physiological development

6.19

18.23

2.4

1.5

—

Spondylopathies

593

2363

1.51

18.19

1.6

—

6-mercaptopurine

4.98

18.09

2.4

1.7

—

Osteonecrosis due to drugs

7.01

18.04

2.6

1.8

—

Pulmonary eosinophilia, not elsewhere classified

7.31

18.01

1.8

1.6

—

Other disorders of lacrimal gland

262

1463

1.80

17.89

1.8

1.5

—

Eosinophilia

5.98

17.76

1.8

—

Mood disorders

735

3334

1.43

17.73

1.7

1.6

—

Pleural plaque with presence of asbestos

319

2.81

17.73

1.6

—

Noninfectious colitis NAS

125

536

2.36

17.69

1.8

1.6

—

Polycystic kidney disease

4.62

17.65

1.9

—

Ascites

245

3.07

17.51

1.6

1.5

—

Mood [affective] disorders

732

3332

1.43

17.49

1.7

1.6

—

Obesity due to excess calories

335

2016

1.67

17.48

1.6

—

Congenital malformations of heart and great arteries

136

589

2.27

17.41

1.7

1.9

—

Dental caries, including avohilmo

580

1976

1.51

17.37

1.6

1.5

—

SLE (Finngen)

4.61

17.35

1.4

1.5

—

Other symptoms and signs involving the digestive system and abdomen

127

554

2.31

17.26

2.0

1.6

—

Malignant neoplasm of kidney, except renal pelvis

263

2.97

17.24

1.3

1.5

—

Malignant neoplasm of urinary organs

290

2.87

17.23

1.3

1.5

—

461

2638

1.55

17.14

1.5

1.6

—

Diseases of spleen

5.74

17.11

1.8

1.5

—

Other and unspecified effects of external causes

209

1105

1.90

17.03

1.7

1.6

—

Problems related to lifestyle

320

2.75

16.97

1.5

1.6

—

Substance use, excluding alcohol

154

735

2.11

16.78

2.0

1.6

—

Cholelithiasis, broad definition with cholecystitis

618

2858

1.46

16.76

1.6

—

Cardiac arrest

129

3.69

16.75

1.6

1.3

—

Viral warts

164

803

2.06

16.69

2.3

1.6

—

Disorders of lacrimal system

310

1847

1.68

16.68

1.8

1.5

—

Mature T/NK-cell lymphomas, hilmo

6.10

16.37

2.2

1.7

—

Injuries to the hip and thigh

367

2075

1.61

16.34

1.5

1.6

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

5.18

16.33

1.8

1.5

—

439

2581

1.54

16.32

1.5

1.6

—

Delirium, not induced by alcohol and other psychoactive substances

119

518

2.32

16.26

1.7

1.6

—

Malignant neoplasm of heart, mediastinum and pleura

7.38

16.25

1.3

1.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

105

432

2.45

16.23

1.6

1.4

—

Cystic kidney disease

127

3.88

16.19

1.9

—

Postprocedural disorders of digestive system, not elsewhere classified

118

4.01

16.19

1.7

—

Mental and behavioural disorders due to alcohol

389

2377

1.58

16.18

1.5

1.6

—

Other (seronegative) rheumatoid arthritis, wide

157

768

2.06

16.07

1.5

1.6

—

Drug-induced polyneuropathy

7.06

15.99

3.6

1.6

—

Other diseases of intestine

124

555

2.26

15.93

1.8

1.5

—

Depression

665

3172

1.42

15.89

1.7

1.6

—

Diseases of oral cavity, salivary glands and jaws

468

1562

1.55

15.88

1.7

1.5

—

Malignant cancer of tonsil and base of tongue

6.03

15.82

1.6

—

Adverse effects, not elsewhere classified

159

789

2.03

15.65

1.8

1.7

—

Sicca syndrome [Sjögren]

289

2.77

15.65

1.6

1.5

—

Psychiatric diseases

729

2593

1.41

15.65

1.6

—

Cystic fibrosis with intestinal manifestations

52.03

15.60

4.3

1.2

—

Malignant neoplasm of oropharynx

6.43

15.59

1.5

1.7

—

Pyogenic arthritis

235

2.98

15.58

1.6

1.7

—

Basal cell carcinoma

277

1113

1.73

15.56

1.7

1.5

—

Other and unspecified polyneuropathies, also in other diseases

168

854

1.99

15.48

1.9

1.5

—

Diabetic maculopathy, excluding more controls

101

419

2.44

15.47

1.4

1.6

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7.42

15.46

1.8

1.7

—

Other diseases of liver

146

706

2.09

15.43

1.7

1.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

302

1811

1.66

15.38

1.7

1.5

—

Arterial embolism and thrombosis

206

3.11

15.27

1.3

1.7

—

Squamous cell neoplasms and carcinomas of the skin

265

2.83

15.23

1.6

1.4

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

5.79

15.19

1.3

1.6

—

Depression or dysthymia

499

1837

1.50

15.18

1.6

—

Tumor necrosis factor alpha inhibitors

125

574

2.20

15.10

1.4

1.8

—

Dilated cardiomyopathy

115

511

2.28

15.10

1.5

1.7

—

Bacterial, viral and other infectious agents

306

2.68

15.09

2.0

1.8

—

Diseases of peritoneum

400

2.46

15.08

1.8

1.7

—

Cholangitis (primary sclerosing, PSC)

235

2.94

15.00

1.7

—

Ulcerative colitis

183

968

1.90

14.97

1.9

1.6

—

Type 1 diabetes

193

1037

1.87

14.96

1.5

1.6

—

Urticaria

215

1197

1.81

14.93

1.8

1.6

—

Malignant neoplasm of breast, HER-negative

118

521

2.24

14.91

1.3

1.4

—

In situ neoplasms

282

1696

1.67

14.87

1.8

1.5

—

Other abnormal findings of blood chemistry

159

3.40

14.84

1.7

—

Basal cell carcinoma, including avohilmo

283

1155

1.70

14.81

1.7

1.5

—

Malignant neoplasm of other connective and soft tissue

4.85

14.80

1.8

1.7

—

Elevated blood glucose level

315

2.64

14.79

2.1

1.7

—

Other diseases of anus and rectum

233

1331

1.76

14.72

1.6

1.5

—

Aortic aneurysm

198

1059

1.85

14.71

1.7

1.5

—

Pneumococcal septicemia

136

3.63

14.70

2.0

1.8

—

Vascular disorders of the intestines

265

2.80

14.70

1.7

1.5

—

Conductive and sensorineural hearing loss

589

2778

1.44

14.70

1.8

1.6

—

Allergic bronchopulmonary aspergillosis (ABPA)

30.76

14.68

3.2

1.1

—

Fibrosis and cirrhosis of liver

305

2.67

14.68

1.6

1.7

—

Gout due to impairment of renal function

6.93

14.64

1.7

1.9

—

Other diseases of biliary tract

358

2.52

14.62

1.5

1.6

—

Cystic fibrosis

25.14

14.56

4.8

1.3

—

Malignant neoplasm of breast, ER-negative, including Hilmo

127

565

2.16

14.56

1.3

1.4

—

Other skin changes

158

804

1.98

14.55

2.0

1.6

—

Vascular diseases of the intestine

132

3.64

14.54

1.5

1.8

—

Microscopic polyangiitis

13.35

14.53

1.9

1.4

—

Hypersensitivity pneumonitis due to organic dust

5.39

14.52

3.0

1.7

—

Other anxiety disorders

294

1549

1.65

14.52

1.8

1.6

—

Adalimumab

336

2.56

14.46

1.4

1.8

—

Complications following infusion, transfusion and therapeutic injection

5.73

14.43

1.9

1.8

—

Osteomyelitis

257

2.81

14.41

1.6

—

Symptoms and signs involving the skin and subcutaneous tissue

501

3373

1.46

14.40

1.8

1.6

—

Fluid overload

23.93

14.39

3.3

1.2

—

Gastroduodenal ulcer

214

1201

1.79

14.36

1.7

1.4

—

ILD and respiratory illness in diseases classified elsewhere

14.29

14.36

3.4

1.3

—

Other diseases of blood and blood-forming organs

236

2.88

14.29

1.6

—

Other disorders of ear

670

3151

1.40

14.27

1.8

1.6

—

317

1814

1.61

14.26

1.7

1.5

—

Arthropathies

632

2257

1.42

14.25

1.5

1.7

—

Fracture of rib(s), sternum and thoracic spine

239

1392

1.73

14.25

1.7

1.5

—

Other and unspecified vasculitis limited to skin

4.37

14.19

1.3

1.7

—

Other and unspecified coagulation defects

154

3.37

14.13

1.7

1.6

—

Diverticular disease of intestine

509

2223

1.47

14.12

1.7

1.6

—

Systemic lupus erythematosus

107

3.92

14.11

1.4

1.6

—

Vasculitis limited to skin, not elsewhere classified

4.16

14.10

1.3

1.7

—

Other hearing loss

226

1273

1.75

14.00

1.6

1.5

—

Crohn disease

109

489

2.25

13.99

1.6

1.7

—

Other symptoms and signs involving the circulatory and respiratory systems

180

3.15

13.99

1.8

1.5

—

Charcot foot

5.71

13.93

1.6

1.7

—

Disorders of lipoprotein metabolism and other lipidaemias

550

2370

1.44

13.88

1.6

1.5

—

Hypertensive Heart Disease

179

745

1.89

13.88

1.4

1.6

—

Cholelithiasis

579

2816

1.42

13.81

1.6

—

Alcohol use disorder, Swedish definition

407

2485

1.51

13.71

1.5

1.6

—

Other and unspecified local infections of skin and subcutaneous tissue

370

2.44

13.64

2.1

1.6

—

Bacterial, viral and other infectious agents

334

2.52

13.64

1.9

1.8

—

Malignant cancer of tonsil and base of tongue, including Hilmo

4.76

13.61

1.6

1.7

—

Malignant neoplasm of brain, including Hilmo

138

3.46

13.60

2.2

1.7

—

Malignant immunoproliferative diseases

6.40

13.57

2.4

1.7

—

Drug-induced osteoporosis

5.82

13.51

2.4

1.4

—

Amputation of foot

102

3.95

13.45

1.2

1.8

—

Other retinal disorders

469

2502

1.47

13.44

1.5

1.6

—

Missing teeth due to accident, extraction or parodontitis

431

2750

1.48

13.44

1.8

1.6

—

Other immunodeficiencies

6.58

13.42

1.9

1.3

—

Malignant neoplasm of tonsil

6.52

13.38

1.4

1.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

419

2828

1.49

13.37

1.6

—

Other local infections of skin and subcutaneous tissue

392

2.38

13.35

2.1

1.6

—

Sensorineural hearing loss

558

2672

1.42

13.33

1.8

1.6

—

Disorders of plasma-protein metabolism, not elsewhere classified

10.18

13.32

5.2

1.5

—

Hypertension, Pulmonary Arterial

12.93

13.32

5.0

1.6

—

Covid-19 suspected case

148

760

1.96

13.28

2.0

1.5

—

Pain in joint

387

1617

1.53

13.25

1.6

1.5

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

112

3.73

13.23

1.9

1.7

—

Malignant neoplasm of oropharynx, including Hilmo

5.06

13.19

1.6

—

Nonsuppurative otitis media

166

762

1.90

13.19

2.1

1.6

—

Disorders of the thyroid gland

659

3119

1.38

13.11

1.5

1.6

—

Seborrhoeic keratosis

173

942

1.85

13.02

2.0

1.5

—

Disorders of choroid and retina

580

2944

1.40

13.01

1.5

1.6

—

Anxiety (asthma-related co-morbidities)

381

1948

1.52

12.97

1.7

1.6

—

Rare circulating lymphoid malignancy

16.91

12.92

1.8

1.2

—

Cystic fibrosis, other manifestations/unspecified

29.04

12.91

4.4

1.3

—

Other coagulation defects

244

2.74

12.89

1.7

1.6

—

SLE, strict definition

105

3.80

12.87

1.5

1.6

—

SLE, ICD10

105

3.80

12.87

1.5

1.6

—

Other gastritis (incl. Duodenitis)

174

954

1.84

12.81

1.9

1.4

—

Misadventures to patients during surgical and medical care

116

554

2.11

12.77

1.6

1.5

—

Selective serotonin reuptake inhibitors

698

2668

1.37

12.75

1.5

1.6

—

Hypertensive Renal Disease

120

3.57

12.71

1.5

—

Mental and behavioural disorders due to opioids

121

3.54

12.55

2.0

1.8

—

Skin changes due to chronic exposure to nonionizing radiation

295

1724

1.59

12.54

1.7

1.5

—

Diseases of the ear and mastoid process

811

3055

1.34

12.53

1.7

1.6

—

Malignant neoplasm of small intestine

5.14

12.49

2.2

1.7

—

Congenital malformations of the urinary system

243

2.72

12.47

1.8

1.9

—

Diabetic retinopathy, excluding more controls

200

626

1.80

12.42

1.5

1.7

—

Benign neoplasms

691

2803

1.36

12.37

1.6

—

Fracture of femur

211

1117

1.72

12.36

1.5

—

Type 1 diabetes, wide definition, subgroup 1

153

815

1.89

12.31

1.6

—

Reactive arthropathies

303

2.50

12.26

1.7

—

Caries of dentine, including avohilmo

584

2134

1.40

12.26

1.6

—

Hernia

654

3221

1.36

12.26

1.7

1.6

—

Idiopathic gout

389

2.32

12.25

1.7

1.6

—

Malignant neoplasm of small intestine, including Hilmo

4.34

12.25

2.0

1.7

—

Open wound of head

404

2658

1.47

12.19

1.6

1.7

—

Carrier of infectious disease

4.13

12.19

1.8

1.5

—

Actinic keratosis

289

1700

1.58

12.18

1.7

1.5

—

IBD patients in KELA-register

160

870

1.85

12.12

1.7

1.6

—

Injuries to the knee and lower leg

828

3487

1.32

12.10

1.6

—

Gingivitis and periodontal diseases

730

2801

1.35

12.08

1.7

1.5

—

Internal derangement of knee

259

1603

1.62

12.05

1.6

1.7

—

Acidosis

4.42

12.03

1.6

1.7

—

Carcinoma in situ of skin of other and unspecified parts of face

343

2.40

12.00

1.8

1.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

163

890

1.83

11.99

1.6

—

Heart failure and hypertrophic cardiomyopathy

4.68

11.99

1.5

1.7

—

Systemic lupus erythematosus, unspecified

3.89

11.97

1.5

1.6

—

Superficial injury of thorax

121

602

2.03

11.97

1.6

—

12.42

11.92

3.5

1.3

—

Ulcerative colitis, NAS

111

536

2.09

11.90

2.0

1.7

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

676

3422

1.35

11.89

1.7

1.6

—

Fracture of lumbar spine and pelvis

171

954

1.80

11.87

1.7

1.5

—

Other/unspecified dorsalgia

265

1651

1.60

11.81

1.9

1.6

—

Abnormal findings on examination of urine, without diagnosis

167

3.05

11.81

1.7

—

Congenital malformations of cardiac septa

340

2.37

11.79

1.8

2.0

—

Acute suppurative otitis media

171

892

1.80

11.70

2.0

1.6

—

Malignant neoplasm, without specification of site, including Hilmo

127

3.35

11.64

1.4

1.5

—

Abnormal findings on diagnostic imaging of other body structures

103

488

2.13

11.62

1.5

—

Mixed connective tissue disease

212

2.78

11.62

2.2

1.5

—

Selective deficiency of immunoglobulin G [IgG] subclasses

12.65

11.55

2.8

1.4

—

Congenital malformations of the urinary system

253

2.61

11.54

1.8

1.9

—

Oesophageal varices

159

3.08

11.52

1.7

1.8

—

Malignant neoplasm of pancreas, including Hilmo

247

2.62

11.52

1.4

—

Speech and linguistic disorders, excluding more controls

281

2.47

11.50

2.2

1.7

—

Crohn's disease NAS

225

2.70

11.45

1.4

1.7

—

Malignant neoplasm of tonsil, including Hilmo

5.53

11.42

1.4

1.7

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

324

2137

1.52

11.42

1.5

1.7

—

Disorders of sclera, cornea, iris and ciliary body

374

2553

1.47

11.40

1.7

1.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

365

2408

1.48

11.37

1.9

1.6

—

Hypopituitarism

291

2.47

11.31

1.9

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

127

657

1.95

11.29

1.6

1.7

—

Personality disorders, excluding more controls

150

818

1.84

11.27

1.8

1.6

—

Malignant neoplasm of endocrine gland

177

2.91

11.23

2.0

1.5

—

Unstable angina pectoris

257

1271

1.60

11.21

1.5

—

Rash and other nonspecific skin eruption

379

2.27

11.19

2.0

1.6

—

Other specific joint derangements/joint disorders

471

2149

1.42

11.18

1.6

1.7

—

Acute posthaemorrhagic anaemia

116

3.43

11.14

1.9

1.6

—

Type 1 diabetes, wide definition

159

886

1.80

11.12

1.6

—

DVT of lower extremities

146

796

1.85

11.03

1.7

1.5

—

Inflammatory bowel disease, strict (require KELA)

160

897

1.79

11.02

1.7

1.6

—

Conjunctivitis (acute, non atopic)

201

1197

1.68

11.01

1.8

1.6

—

Melanocytic naevi

198

1179

1.69

11.01

1.8

1.6

—

Haemophagocytic lymphohistiocytosis

31.71

10.98

2.4

1.3

—

Disorders of oesophagus in diseases classified elsewhere

4.20

10.95

3.2

1.5

—

Asthma mixed form (mode), excluding more controls

4.67

10.94

1.8

1.1

—

Spondyloarthritis

127

664

1.93

10.91

1.5

1.6

—

Other specified/unspecified necrotizing vasculopathies

5.30

10.88

1.9

1.6

—

Systemic sclerosis (FG)

4.28

10.87

2.6

1.6

—

Hypoplasia of dental enamel, prenatal , including avohilmo

5.40

10.85

2.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

293

1923

1.53

10.84

1.6

—

Other headache syndromes

263

1684

1.57

10.83

1.6

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

244

2.58

10.79

1.6

—

Statin medication

450

1777

1.43

10.75

2.0

1.5

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

316

2093

1.50

10.73

1.7

1.6

—

All anxiety disorders

384

2093

1.45

10.73

1.7

1.6

—

Faecal incontinence

274

2.47

10.72

1.6

1.4

—

Malignant neoplasm of pancreas

200

2.73

10.58

1.3

1.4

—

Polyarteritis nodosa and related conditions

4.96

10.58

1.9

1.5

—

Psoriatic and enteropathic arthropathies

388

2.21

10.58

1.3

1.7

—

Periodontitis

655

3297

1.33

10.56

1.8

1.6

—

Cirrhosis of liver, NAS

201

2.73

10.51

1.5

1.7

—

Need for immunization against other single viral diseases

4.18

10.50

2.7

1.5

—

Myeloproliferative diseases

327

2.32

10.45

1.6

—

Carcinoma in situ of skin of scalp and neck

102

3.53

10.38

1.7

1.5

—

Nerve, nerve root and plexus disorders

721

3372

1.31

10.36

1.6

—

Hypothyroidism, other/unspecified

590

2884

1.35

10.34

1.5

1.6

—

Other dorsopathies, not elsewhere classified

678

2676

1.33

10.33

1.6

—

Unknown and unspecified causes of morbidity

137

3.09

10.31

2.4

1.5

—

Secondary malignant neoplasm of other and unspecified sites

4.83

10.31

1.3

1.6

—

Hypoparathyroidism

112

3.37

10.31

2.0

1.6

—

Other salmonella infections

112

3.36

10.30

1.8

1.9

—

Atopic dermatitis, strict definition with reimbursement

188

1085

1.68

10.27

1.5

1.6

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

612

3005

1.34

10.24

1.5

1.6

—

Superficial injury of hip and thigh

117

609

1.94

10.23

1.6

—

Diseases of middle ear and mastoid

368

2085

1.45

10.15

1.7

1.6

—

Alcohol use disorder, ICD-based

295

1970

1.50

10.11

1.5

1.7

—

Non-selective monoamine reuptake inhibitors

249

1543

1.56

10.11

1.7

1.6

—

Chronic ulcer of skin, not elsewhere classified

258

2.47

10.10

1.5

1.6

—

Other diseases of oesophagus

383

2.19

10.09

2.3

1.5

—

Disorders of refraction and accommodation

188

1127

1.67

10.08

1.8

1.7

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

8.02

10.06

1.5

1.6

—

Schizophrenia or delusion, excluding more controls

188

1123

1.66

9.96

1.6

—

Neuromuscular dysfunction of bladder

334

2.27

9.95

1.5

1.6

—

Gonarthrosis [arthrosis of knee](FG)

478

2004

1.39

9.94

1.5

1.6

—

Congenital malformations of aortic and mitral valves

168

2.85

9.90

1.6

2.1

—

Ventral hernia

178

1063

1.69

9.86

1.7

1.5

—

Hypoplasia of dental enamel, prenatal

9.30

9.84

2.5

2.2

—

Paracetamol or NSAID medication

124

320

1.96

9.79

1.7

1.6

—

Chronic periodontitis, including avohilmo

647

3299

1.32

9.73

1.8

1.6

—

Other (not insulin) diabetes medications

631

2831

1.33

9.70

1.5

1.6

—

Malignant neoplasm of bone and articular cartilage

8.77

9.69

1.5

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

13.91

9.67

2.3

1.8

—

Open wound of lower leg

117

622

1.90

9.64

1.6

—

Isolated proteinuria

107

3.35

9.64

1.5

1.7

—

Malignant neoplasm of oral cavity, including Hilmo

117

3.21

9.61

1.5

—

Other diseases of arteries and capillaries

333

2.25

9.59

1.8

1.5

—

Procreative management

223

1176

1.59

9.55

2.2

1.7

—

Hernia of abdominal wall

324

2233

1.46

9.51

1.6

—

Superficial injury of lower leg

168

1000

1.69

9.44

1.7

1.6

—

Disorders of magnesium metabolism

7.75

9.42

1.3

1.7

—

Other autoimmune haemolytic anaemias

5.06

9.40

1.9

—

Other specified/unspecified systemic involvement of connective tissue

184

2.70

9.40

2.3

1.5

—

Other diseases of upper respiratory tract

778

3162

1.29

9.33

1.7

1.6

—

Suggestive for eosinophilic asthma

318

2.26

9.32

1.6

—

Colorectal cancer

141

784

1.77

9.31

1.3

1.5

—

Decubitus ulcer and pressure area

238

2.47

9.30

1.6

—

Mental and behavioural disorders due to sedatives or hypnotics

232

2.49

9.28

1.9

1.8

—

L02BG Aromatase inhibitors

182

1110

1.65

9.26

1.4

1.5

—

Exclusions for E4_PCOS_CONSORTIUM

436

1972

1.39

9.16

1.6

—

Medical observation and evaluation for suspected diseases and conditions

477

1777

1.38

9.15

1.7

1.5

—

Gastric ulcer

136

771

1.78

9.13

1.9

1.4

—

Dorsopathies

693

2713

1.30

9.10

1.5

1.6

—

Inflammatory diseases of the central nervous system

315

2.25

9.10

1.7

—

Seronegative rheumatoid arthritis

407

2.08

9.05

1.3

1.6

—

Cytomegaloviral pneumonitis

20.09

9.01

3.6

1.3

—

Traumatic subdural haemorrhage

104

522

1.93

8.97

1.3

1.4

—

Cerebrovascular diseases

516

2708

1.34

8.96

1.6

—

Reactive arthropathies, FINNGEN

230

2.46

8.96

1.6

1.7

—

Malignant neoplasm of colon, including Hilmo

118

644

1.84

8.95

1.3

1.5

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

9.09

8.94

2.8

1.6

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

228

1482

1.55

8.94

1.7

1.6

—

Rheumatism, unspecified

463

2.00

8.93

1.6

1.5

—

Explicit fungal Sepsis

10.05

8.93

1.8

1.4

—

Personal history of other diseases and conditions

335

2.19

8.92

2.1

1.5

—

Polyarthrosis

137

725

1.76

8.92

1.6

—

Malignant neoplasm of adrenal gland, including Hilmo

10.01

8.91

1.8

1.4

—

Thoracic aortic aneurysm

114

618

1.86

8.90

1.7

1.6

—

Malignant neoplasm of testis, including Hilmo

4.57

8.88

1.7

2.1

—

Other Crohn's disease

225

2.47

8.88

1.5

1.8

—

Asthma mixed form (mode)

3.94

8.86

1.8

1.2

—

Idiopathic thrombocytopenic purpura

113

3.16

8.85

1.3

1.6

—

Medicines for HER+ breast cancer

213

1293

1.57

8.84

1.4

1.5

—

Other diseases of stomach and duodenum

244

2.41

8.83

1.9

1.5

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

425

2.04

8.81

1.8

1.9

—

Erythema nodosum

3.40

8.80

1.7

1.6

—

Suppurative and unspecified otitis media

220

1257

1.56

8.78

1.9

1.6

—

Soft tissue disorders

700

2796

1.29

8.76

1.6

—

Sub-endpoint used in defining T1D endpoints

208

1309

1.57

8.74

1.6

—

Other special examinations and investigations of persons without complaint or reported diagnosis

478

1777

1.37

8.74

1.8

1.5

—

FESS (DNB20)

481

1.97

8.73

1.9

1.6

—

Systemic sclerosis

3.62

8.73

2.6

1.5

—

Clear cell adenocarcinoma of kidney

119

3.07

8.72

1.1

1.5

—

Varicella [chickenpox]

163

2.74

8.70

2.3

1.9

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

180

2.64

8.69

1.9

1.5

—

Coronary artery bypass grafting

182

833

1.64

8.68

1.3

1.5

—

Fitting and adjustment of external prosthetic device

22.11

8.67

2.9

1.2

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

4.92

8.66

1.7

1.4

—

Stroke, excluding SAH

429

2289

1.37

8.65

1.6

—

Secondary polycythaemia

3.68

8.61

2.0

1.8

—

Injuries to the ankle and foot

448

2946

1.35

8.58

1.6

—

Malignant neoplasm of adrenal gland

13.88

8.56

1.8

1.5

—

Ethmoidectomy

499

1.94

8.53

1.9

1.6

—

Polycythaemia vera

3.47

8.53

1.8

1.6

—

Functional dyspepsia

172

1060

1.63

8.50

2.3

1.5

—

Acute nasopharyngitis (common cold)

361

2.11

8.48

1.8

1.5

—

Dermatographic urticaria

200

2.53

8.48

2.1

1.6

—

Insulin, fast-acting (human)

493

1.94

8.47

1.4

1.6

—

Amputation of ankle bones

3.54

8.43

1.9

1.6

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

534

2730

1.32

8.42

1.5

1.6

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

343

1926

1.41

8.37

1.5

1.6

—

Diseases of the myoneural junction and muscle

524

1.91

8.35

1.5

1.7

—

Other obstetric conditions, not elsewhere classified

138

501

1.76

8.35

1.4

1.5

—

Other salmonella infections

133

2.90

8.35

1.8

—

Other joint disorders

559

2237

1.32

8.30

1.6

1.7

—

Mucosal proctocolitis

469

1.95

8.29

1.9

1.7

—

Carcinoma in situ of skin

355

2.11

8.25

2.2

1.5

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

134

484

1.76

8.21

1.3

1.5

—

Other and unspecified haemorrhagic conditions

4.46

8.20

1.4

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

105

570

1.86

8.18

1.6

—

Viral infections of the central nervous system

253

2.32

8.16

1.6

1.8

—

Infective bursitis

103

3.17

8.15

1.6

2.0

—

Shock, not elsewhere classified

12.07

8.14

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

129

660

1.75

8.13

1.9

1.7

—

Visual disturbances and blindness

346

2486

1.40

8.11

1.6

—

Bipolar affective disorders

113

629

1.81

8.11

1.5

1.7

—

Recurrent or chronic depression

246

1155

1.50

8.09

1.8

1.7

—

Poisoning by drugs, medicaments and biological substances

145

867

1.68

8.08

1.7

1.6

—

Stroke, including SAH

444

2394

1.35

8.07

1.6

—

Aortic valve malfunction, age under 60 years

365

2.08

8.05

1.9

—

Status epilepticus

136

2.84

8.04

1.9

1.7

—

Malignant neoplasm of eye, brain and central nervous system

125

2.92

8.03

2.3

1.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

159

2.69

8.01

2.2

1.7

—

Systemic sclerosis, icd10

3.41

7.98

2.6

1.6

—

Spondylopathies in diseases classified elsewhere

4.57

7.97

1.9

1.8

—

Chronic myeloproliferative disease

4.56

7.96

1.5

1.9

—

Intestinal malabsorption

148

2.74

7.95

1.8

—

Viral infections of the central nervous system

275

2.24

7.95

1.6

1.7

—

Late syphilis

4.04

7.94

1.3

1.8

—

Malignant neoplasm of testis

4.52

7.94

1.6

2.2

—

Dizziness and giddiness

499

3003

1.32

7.94

1.6

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

126

2.91

7.94

2.3

1.7

—

Abnormal blood-pressure reading, without diagnosis

115

2.99

7.94

1.3

1.6

—

Papulosquamous disorders

257

1759

1.47

7.92

1.6

—

Keratitis

234

1572

1.49

7.92

1.9

1.6

—

Acute alcohol intoxication

183

1166

1.58

7.91

1.5

1.6

—

Seborrhoeic dermatitis

381

2.04

7.91

2.1

1.6

—

Injuries to unspecified part of trunk, limb or body region

415

1.99

7.91

1.5

1.7

—

Drug-induced interstitial lung disorders, unspecified

21.39

7.89

1.8

2.2

—

Epilepsy

213

1400

1.52

7.89

1.8

1.6

—

Weight loss

430

1.97

7.86

2.1

1.6

—

Etanercept

214

2.41

7.84

1.5

1.8

—

Chronic rhinitis, nasopharyngitis and pharyngitis

201

1311

1.54

7.82

1.7

1.6

—

Crohn's disease of small intestine

239

2.33

7.82

1.6

1.7

—

Other disorders of bone

125

725

1.73

7.81

1.6

—

Diabetic retinopathy, strict definition

137

717

1.70

7.79

1.5

1.6

—

Encephalitis

106

3.08

7.78

1.6

1.7

—

Other specified disorders of kidney and ureter

117

2.96

7.74

2.1

1.8

—

Left ventricular outflow tract obstruction, narrow definition

222

2.38

7.73

1.6

2.0

—

Implicit parasitic Sepsis

12.51

7.69

2.8

1.5

—

Other disorders of veins

246

1671

1.47

7.66

1.5

—

Chronic periodontitis, complicated

365

2649

1.37

7.66

1.8

1.6

—

Visual disturbances

318

2278

1.40

7.64

1.6

—

Chronic tubulo-interstitial nephritis

107

3.03

7.63

2.1

1.5

—

Alcohol dependence

187

1208

1.56

7.63

1.4

1.7

—

Polycystic ovarian syndrome, consortium definition

380

1639

1.38

7.62

1.6

1.5

—

Acute alcohol intoxication, ICD10

141

852

1.66

7.60

1.4

1.6

—

Non-small cell lung cancer, squamous

146

2.70

7.59

1.3

1.5

—

malignant neoplasm of male genital organs

187

723

1.58

7.58

1.5

1.7

—

Other disorders of optic [2nd] nerve and visual pathways

249

2.28

7.57

2.1

1.8

—

Syphilis

3.28

7.57

1.9

—

Syphilis

3.28

7.57

1.9

—

Ischaemic Stroke, excluding all haemorrhages

396

2177

1.36

7.56

1.5

1.6

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

135

2.77

7.56

1.8

1.6

—

Disorders of optic nerve and visual pathways

347

2.06

7.56

2.0

1.8

—

Malignant melanoma, including Hilmo

100

549

1.83

7.55

1.5

—

Tuberculosis, IBD comorbidity

262

2.24

7.54

1.9

1.6

—

Late syphilis

4.35

7.54

1.4

1.8

—

Alcohol abuse, main dg, excluding more controls

535

1.84

7.53

1.4

1.7

—

Dermatopolymyositis (FG)

4.34

7.53

2.2

1.6

—

Varicella [chickenpox]

206

2.41

7.51

2.2

1.9

—

Other encephalitis

3.12

7.48

1.6

1.7

—

D07AA Corticosteroids, weak (group I)

115

660

1.75

7.45

1.7

1.8

—

Examination and observation for other reasons

411

1759

1.36

7.45

1.9

1.5

—

Amyloidosis

3.41

7.43

1.8

1.4

—

Abnormal weight loss

384

2.00

7.40

2.0

1.6

—

Other and unspecified myopathies

350

2.05

7.40

1.4

1.7

—

Colorectal adenocarcinoma

115

661

1.74

7.38

1.3

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

150

928

1.63

7.38

1.5

—

Hepatomegaly and splenomegaly, not elsewhere classified

7.07

7.38

2.1

1.6

—

Glaucoma

377

2396

1.36

7.37

1.5

—

Coxarthrosis [arthrosis of hip](FG)

340

1730

1.39

7.36

1.7

1.6

—

Myalgia

149

921

1.63

7.35

1.4

1.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

16.79

7.34

2.8

1.1

—

Malignant neoplasm of bone and articular cartilage of limbs

16.77

7.34

1.4

1.3

—

Disorders of conjunctiva

528

3281

1.29

7.33

1.7

1.6

—

Disorders of skin appendages

290

2058

1.41

7.33

1.8

1.6

—

Injuries to the shoulder and upper arm

563

3542

1.28

7.32

1.6

—

Unspecified chronic bronchitis

105

2.99

7.25

3.0

1.6

—

Lichen simplex chronicus and prurigo

216

2.34

7.24

1.6

—

Tuberculosis

235

2.28

7.23

1.9

1.6

—

Pulmonary oedema

4.00

7.19

1.4

1.6

—

Implicit parasitic Sepsis

12.77

7.19

2.3

1.6

—

Disorders of continuity of bone

320

2.08

7.19

1.6

1.7

—

Visual field defects

334

2.06

7.17

1.6

1.7

—

Other arterial embolism and thrombosis

106

2.98

7.16

1.4

1.7

—

Malignant neoplasm, without specification of site

3.30

7.13

1.4

1.6

—

Otitis media, unspecified

402

1.91

7.09

2.4

1.6

—

Discitis, unspecified

3.70

7.08

1.8

2.0

—

Disorders of psychological development

478

1.84

7.07

2.3

1.7

—

Other diseases of hard tissues of teeth

401

1538

1.35

7.04

1.7

1.5

—

Primary adrenocortical insufficiency

4.50

7.02

1.2

1.5

—

Carcinoma in situ of skin of upper limb, including shoulder

102

3.01

7.02

1.9

1.5

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

232

2.26

6.99

1.6

1.8

—

Malignant neoplasm of brain

102

2.98

6.99

2.5

1.7

—

Metabolic disorder, other/unspecified

12.03

6.98

2.8

1.7

—

Convalescence

141

2.65

6.98

1.5

—

Psoriasis

184

1210

1.53

6.97

1.6

—

Hypersensitivity angiitis

8.82

6.97

1.7

1.4

—

Respiratory tuberculosis

195

2.39

6.96

1.9

1.7

—

Hereditary hypogammaglobulinemia

11.86

6.95

2.8

1.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

306

2.08

6.95

1.9

1.8

—

Infective dermatitis

436

1.90

6.90

1.6

—

Respiratory tuberculosis, confirmed and not-confirmed

196

2.37

6.89

1.9

1.7

—

Viral encephalitis, not elsewhere classified/unspecified

3.51

6.88

1.4

1.6

—

Hepatic failure, not elsewhere classified

131

2.71

6.86

1.4

1.8

—

Postzoster neuralgia

3.87

6.86

1.8

1.6

—

Schizophrenia, schizotypal and delusional disorders

192

1279

1.51

6.84

1.6

—

Right ventricular outflow tract obstruction

4.07

6.82

1.8

1.9

—

Hyperfunction of pituitary gland

137

2.66

6.82

1.9

1.6

—

Isolated proteinuria with specified morphological lesion

4.39

6.81

1.2

1.5

—

Nonorganic sleeping disorders, excluding more controls

111

649

1.72

6.80

1.9

1.6

—

Hypertrophic cardiomyopathy

161

2.52

6.79

1.6

1.9

—

4.31

6.77

1.8

1.5

—

Other inflammatory liver diseases

242

2.21

6.76

1.8

1.7

—

Adenocarcinoma and ductal carcinoma of pancreas

3.11

6.76

1.3

1.7

—

Speech and linguistic disorders

387

1.93

6.75

2.2

1.7

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

577

1.76

6.73

1.6

1.7

—

Common variable immunodeficiency

8.21

6.72

1.6

1.7

—

Left bundle-branch block

217

2.28

6.71

1.5

—

Unspecified privation

426

1.89

6.71

1.8

1.6

—

Chronic myeloid leukaemia, including Hilmo

8.06

6.68

1.9

1.8

—

Symptoms and signs involving speech and voice

213

1457

1.47

6.68

1.5

1.6

—

Amenorrhoea

168

2.46

6.67

1.5

—

Heterophoria

296

2.08

6.67

2.0

1.8

—

Dermatophytosis

528

1.79

6.65

1.7

1.5

—

Prurigo nodularis

3.16

6.63

1.8

1.6

—

Myeloproliferative diseases (CML excluded)

297

2.08

6.62

1.5

1.6

—

Tuberculosis, wide

277

2.11

6.62

1.9

1.6

—

205

1210

1.48

6.61

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

345

1.99

6.59

1.8

—

Personality disorders

150

955

1.58

6.59

1.8

1.7

—

Vitreous haemorrhage

422

1.89

6.58

1.6

—

Malignant neoplasm of larynx, including Hilmo

3.87

6.56

1.7

1.6

—

Hyperkinetic disorders, excluding more controls

297

2.04

6.55

1.8

1.6

—

Carcinoma in situ of skin, other sites/unspecified

3.75

6.54

2.5

1.5

—

Thrombotic microangiopathy

7.78

6.52

1.6

1.2

—

Other diseases of pancreas

347

1.98

6.50

1.3

1.7

—

Hordeolum and other deep inflammation of eyelid

189

2.35

6.49

1.6

—

Amiodarone users

446

1.86

6.47

1.6

—

Diabetic retinopathy

252

1102

1.43

6.45

1.5

1.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

163

1064

1.54

6.42

1.6

—

Thyrotoxicosis, other and/or unspecified

125

767

1.64

6.42

1.6

—

Acute and subacute iridocyclitis

127

783

1.63

6.40

1.6

—

Psoriatic arthropathies

342

1.97

6.39

1.3

1.7

—

Unspecified nephritic syndrome

3.22

6.33

2.0

1.6

—

149

898

1.57

6.33

1.4

—

Unspecified misadventure during surgical and medical care

204

2.28

6.32

1.8

1.7

—

Fissure and fistula of anal and rectal regions

150

965

1.56

6.32

1.5

—

Malignant neoplasm of tongue, including Hilmo

3.29

6.31

1.7

—

Other and unspecified diseases of blood and blood-forming organs

2.99

6.31

1.6

1.7

—

Other and unspecified follicular disorders

137

2.59

6.30

1.7

1.8

—

Diabetic maculopathy

100

547

1.74

6.29

1.4

1.7

—

Other disorders starting during childhood or adolecense, excluding more controls

183

2.33

6.28

2.6

1.5

—

Impotence

224

2.22

6.28

2.3

1.8

—

Spontaneous rupture of synovium and tendon

317

2.01

6.27

1.6

1.7

—

Other follicular disorders

237

2.17

6.25

1.6

1.8

—

Viral agents as the cause of diseases classified to other chapters

3.11

6.23

2.2

1.7

—

Melanocytic naevi of trunk

452

1.83

6.21

1.7

1.6

—

Schizophrenia

102

599

1.71

6.20

1.6

1.7

—

Injury of unspecified body region

305

2.02

6.19

1.5

1.8

—

Attention to artificial openings

121

2.68

6.17

2.3

1.7

—

Schizophrenia or delusion

188

1276

1.48

6.17

1.6

—

Malignant neoplasm of prostate, including Hilmo

181

712

1.52

6.16

1.5

1.7

—

Injuries to the elbow and forearm

440

3002

1.29

6.16

1.6

—

Cardiac murmurs and other cardiac sounds

295

2.02

6.15

1.6

1.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

204

1408

1.45

6.15

1.7

1.6

—

Testicular hypofunction

110

2.77

6.14

2.8

2.1

—

Conotruncal defects

2.98

6.14

2.1

2.0

—

Need for other prophylactic measures

226

2.19

6.14

2.1

1.8

—

Hypersplenism

10.64

6.13

2.0

1.6

—

Cardiomyopathy, Hypertrophic obstructive

3.82

6.12

1.8

1.9

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

233

2.17

6.10

1.2

1.8

—

Allergic urticaria

293

2.03

6.10

1.9

1.6

—

Anterior Iridocyclitis

133

841

1.59

6.07

1.5

1.6

—

Dermatopolymyositis

3.54

6.06

2.1

1.5

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

6.21

6.06

1.3

—

Hypertrophy of (infrapatellar) fat pad

5.71

6.06

2.1

1.7

—

Conjunctivitis

457

2981

1.28

6.05

1.7

1.6

—

Acute lymphadenitis

189

2.30

6.04

1.9

1.8

—

Irregular menses

233

1298

1.42

6.02

1.6

1.5

—

Disorders of tooth development and eruption

101

479

1.71

6.00

1.9

1.4

—

Crohn's disease of large intestine

171

2.36

5.99

1.7

1.9

—

Septal defects

343

1.94

5.99

1.8

2.0

—

Other mycoses, not elsewhere classified/unspecified

8.69

5.99

2.1

1.3

—

Iridocyclitis

144

933

1.55

5.92

1.5

1.6

—

Crystal arthropathies, rheuma endpoint

3.46

5.90

1.6

—

Other crystal arthropathies

3.46

5.90

1.6

1.7

—

Other or unspecified immunodeficiency

11.87

5.90

2.8

1.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

146

950

1.54

5.89

1.5

1.6

—

Other obstructive and reflux uropathy

130

2.57

5.88

1.5

1.6

—

Other ulcerative colitis

198

2.24

5.86

1.9

1.8

—

Kela-code for severe mental illness

218

1538

1.42

5.85

1.5

1.6

—

Other neurological diseases

476

2948

1.27

5.85

1.6

—

Other erythematous conditions

119

2.64

5.83

1.7

—

Superficial injury of abdomen, lower back and pelvis

101

603

1.68

5.81

1.6

1.7

—

Bicuspidal aortic valve syndrome

137

2.52

5.80

1.5

2.0

—

Chronic hepatitis, not elsewhere classified

108

2.72

5.78

2.2

1.8

—

Folate deficiency anaemia

5.76

5.75

3.3

1.6

—

Somnolence, stupor and coma

162

2.37

5.75

1.5

1.7

—

Brachial plexus disorders

286

2.01

5.74

1.2

1.7

—

Eustachian salpingitis and obstruction

239

2.11

5.74

1.8

1.7

—

Congenital malformations of great arteries

160

2.40

5.71

1.6

2.0

—

Colectomy operation

118

737

1.61

5.71

1.8

1.6

—

Short stature, not elsewhere classified

162

2.35

5.70

2.2

2.0

—

Cholecystectomy

440

2977

1.28

5.70

1.6

—

Mental retardation, excluding more controls

158

2.37

5.68

1.7

1.9

—

Infections with a predominantly sexual mode of transmission

198

1284

1.44

5.66

1.7

1.6

—

Open wound of ankle and foot

422

1.81

5.66

1.5

1.7

—

Diseases of male genital organs

382

1469

1.32

5.66

1.8

1.7

—

Adult-onset Still disease

13.55

5.65

1.8

1.3

—

Other/unspecified reactive arthropathies

234

2.11

5.65

1.7

—

Pleural plaque without asbestos

145

2.45

5.65

1.8

1.5

—

Melanocytic naevi, other sites/unspecified

288

2.00

5.65

2.2

1.8

—

Arterial embolism and thrombosis of lower extremity artery

127

2.55

5.63

1.3

1.7

—

Gonarthrosis

399

1749

1.30

5.63

1.6

1.7

—

Spondylopathies (FG)

459

1.77

5.63

1.2

1.6

—

Intercostal neuropathy

6.75

5.62

1.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

5.14

5.61

1.6

1.7

—

Migraine

262

1550

1.37

5.61

1.6

—

Atopic dermatitis, strict definition

169

1122

1.48

5.60

1.6

1.7

—

Viral agents as the cause of diseases classified to other chapters

2.84

5.60

2.2

1.7

—

Dronedarone medication

2.97

5.60

1.4

1.7

—

Fracture of foot, except ankle

145

954

1.53

5.58

1.5

1.6

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

3.91

5.58

2.3

1.7

—

Congenital malformations of pulmonary and tricuspid valves

3.79

5.57

1.6

2.0

—

Other and unspecified urticaria

121

765

1.59

5.56

1.7

—

Voice disturbances

163

1100

1.49

5.56

1.5

1.6

—

Dislocation, sprain and strain of joints and ligaments of head

146

2.43

5.56

1.9

2.1

—

Other specified/unspecified inflammatory spondylopathies

134

2.49

5.54

1.2

1.9

—

Poisoning by medicine

127

813

1.57

5.53

1.7

1.6

—

Acute epiglottitis

4.70

5.52

1.6

1.3

—

Early complications of trauma

153

2.38

5.50

1.7

1.9

—

!Aliquae complicationes praecoces traumatis

153

2.38

5.50

1.7

1.9

—

Superficial injury of head

154

1030

1.50

5.49

1.4

1.6

—

Appendectomy

383

2843

1.29

5.47

1.7

1.6

—

Other disorders of eyelid

282

1999

1.35

5.45

1.6

1.5

—

Varicose veins

380

2218

1.30

5.45

1.5

1.6

—

Other inflammation of eyelid

531

1.71

5.45

1.7

1.5

—

Migraine without aura

101

614

1.65

5.44

1.8

1.7

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

268

1.91

5.43

1.4

1.3

—

Other viral hepatitis

218

2.13

5.42

1.3

1.8

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

113

708

1.60

5.41

1.9

1.6

—

Leiomyosarcoma

8.16

5.40

1.6

1.4

—

Other or unspecified common variable immunodeficiency

9.78

5.40

1.5

2.1

—

Spirochaetal infections, other/unspecified

1342

0.59

5.39

1.5

1.6

—

Injuries to the neck

137

898

1.53

5.38

1.5

1.6

—

Type of accident

184

1280

1.44

5.38

1.7

1.6

—

Coxarthrosis

316

1571

1.33

5.38

1.7

—

Malignant melanoma

451

1.76

5.37

1.5

—

Alcohol withdrawal state with delirium

294

1.96

5.36

1.4

1.9

—

Amyloidosis, other/unspecified

3.24

5.35

1.6

1.5

—

Carcinoma in situ of skin of trunk

131

2.48

5.32

1.8

1.5

—

Glaucoma secondary to other eye disorders

143

2.41

5.32

1.5

1.7

—

Malignant neoplasm of colon

497

1.72

5.32

1.3

1.5

—

Other and unspecified psoriasis

240

2.06

5.31

1.6

1.8

—

Sequelae of other external causes

194

2.19

5.29

2.0

1.7

—

L04AC Interleukin inhibitors

194

2.19

5.29

1.3

1.9

—

Lyme disease

1335

0.59

5.29

1.5

1.6

—

Inflammatory diseases of female pelvic organs

305

1688

1.33

5.28

1.6

1.5

—

Right bundle-branch block

2.74

5.28

1.3

1.7

—

Ulcerative colitis (strict definition, require KELA)

105

651

1.62

5.26

2.0

1.6

—

conjunctival haemorrhage

310

1.92

5.26

2.0

1.6

—

Other shoulder lesions

338

1.88

5.26

1.9

1.7

—

Meniscus derangement

341

1756

1.31

5.24

1.6

1.7

—

Other other unspecified disorders of the circulatory system

138

2.42

5.24

1.4

1.7

—

Ulcerative ileocolitis

132

2.45

5.22

1.9

2.0

—

Malignant neoplasm of prostate

171

695

1.48

5.22

1.5

1.7

—

Crohn disease (strict definition, require KELA)

215

2.11

5.21

1.2

1.8

—

Lesion of lateral popliteal nerve

176

2.24

5.21

2.0

1.8

—

Cerebral palsy and other paralytic syndromes

441

1.76

5.20

1.7

1.8

—

Fracture of shoulder and upper arm

231

1681

1.38

5.19

1.6

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

3.39

5.19

1.8

1.6

—

Hepatocellular carcinoma

3.39

5.19

1.8

1.6

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

9.06

5.19

1.6

1.2

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.99

5.18

1.8

1.6

—

Fibromyalgia

263

1.99

5.16

1.4

1.5

—

Sciatica+with lumbago

309

2162

1.32

5.16

1.5

1.6

—

Malignant neoplasm of thyroid gland, including Hilmo

183

2.20

5.15

2.0

1.5

—

Lupus nephritis

8.84

5.15

1.1

1.2

—

Malignant neoplasm of thyroid gland

158

2.30

5.12

2.1

1.5

—

Personal history of certain other diseases

4.51

5.07

1.9

1.4

—

Obesity, other/unspecified

186

1312

1.42

5.06

1.6

—

Suicide or other Intentional self-harm

139

927

1.51

5.06

1.7

1.6

—

Artificial joint operation, meniscal resection

591

3143

1.22

5.06

1.6

—

Respiratory tuberculosis, confirmed

3.01

5.02

1.9

1.6

—

Congenital malformations of the respiratory system

111

2.59

5.02

1.6

1.8

—

Abnormality of white blood cells, not elsewhere classified

5.18

5.00

1.9

1.4

—

Somatoform disorder

590

1.63

5.00

1.6

—

Myositis

2.85

5.00

2.2

1.7

—

Congenital malformations of cardiac chambers and connections

3.52

4.99

2.1

2.2

—

Other spirochaetal diseases

1363

0.61

4.98

1.5

1.6

—

Mesothelioma, including Hilmo

4.44

4.98

1.4

—

Acute nephritic syndrome

3.08

4.97

1.5

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

111

2.55

4.97

1.4

2.0

—

Defects in the complement system

6.24

4.97

1.2

1.5

—

Malignant neoplasm of rectum, including Hilmo

388

1.79

4.97

1.5

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

288

1.92

4.95

1.3

1.5

—

Malignant melanoma of skin, including Hilmo

455

1.72

4.95

1.3

1.5

—

Disorders of muscles

396

1.78

4.95

1.8

1.6

—

Cholecystitis

592

1.63

4.95

1.5

—

Unspecified mental disorder

233

1714

1.36

4.94

1.5

1.6

—

Crohn disease (strict definition, require KELA, min 2 HDR)

213

2.08

4.94

1.2

1.8

—

Polymyositis

4.73

4.94

1.8

1.7

—

Other spirochaetal diseases

1347

0.61

4.93

1.5

1.6

—

Essential (haemorrhagic) thrombocythaemia

2.69

4.92

1.4

1.6

—

Urethral stricture

227

2.05

4.92

2.1

1.7

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

100

624

1.61

4.91

2.1

1.6

—

Rapidly progressive nephritic syndrome

9.85

4.91

2.2

1.5

—

Disorders of adult personality and behaviour

150

1023

1.47

4.90

1.6

1.7

—

Retinal haemorrhage

2.82

4.90

2.4

1.6

—

Non-small cell lung cancer, squamous, helper endpoint

181

2.18

4.89

1.3

1.7

—

Neovascular glaucoma

149

2.31

4.88

1.5

1.7

—

Infectious mononucleosis

241

2.00

4.88

1.4

1.7

—

Osteomyelitis of vertebra

9.63

4.88

3.1

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

204

1466

1.39

4.87

1.6

1.7

—

Benign neoplasm of mouth and pharynx

428

1.74

4.86

1.5

1.6

—

Duodenal ulcer

458

1.71

4.85

1.4

1.5

—

Congenital malformations of the respiratory system

113

2.54

4.84

1.6

1.8

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

277

1.93

4.81

1.3

1.5

—

Chronic gastritis

175

1234

1.42

4.81

2.2

1.4

—

Thyrotoxicosis

147

1004

1.47

4.79

1.5

1.6

—

Emotional disorders starting during childhood or adolecense, excluding more controls

122

2.42

4.77

2.4

1.6

—

Use of antiglaucoma preparations and miotics

314

1.86

4.75

1.4

1.5

—

Testicular dysfunction

126

2.41

4.74

2.8

2.1

—

Other diseases of spinal cord

108

2.54

4.73

2.3

1.8

—

Viral hepatitis

265

1.94

4.73

1.4

1.8

—

Progressive systemic sclerosis

7.52

4.72

3.7

1.5

—

Emotionally unstable personality disorder

358

1.80

4.71

1.7

—

Hypocalcemia

2.75

4.71

1.4

1.9

—

Otitis externa, unspecified

425

1.73

4.70

2.1

1.7

—

Other and unspecified acquired haemolytic anaemias

4.43

4.69

2.9

1.9

—

Herpesviral keratitis and keratoconjunctivitis

152

2.26

4.68

2.1

1.6

—

Iron deficiency

2.87

4.67

1.9

1.5

—

Localized skin eruption due to drugs and medicaments

3.58

4.65

1.7

1.5

—

Malignant neoplasm of liver and intrahepatic bile ducts

2.79

4.63

1.9

1.5

—

Other abnormal uterine and vaginal bleeding

133

636

1.50

4.62

1.6

1.5

—

Other degenerative diseases of the nervous system

165

860

1.44

4.61

1.5

—

Heartburn

346

1.80

4.61

1.5

—

Other abnormal immunological findings in serum

3.02

4.58

2.3

1.5

—

Orchitis and epididymitis

406

1.74

4.58

1.7

—

Arthrosis

427

1870

1.26

4.57

1.5

1.7

—

Persons encountering health services for examination and investigation

443

1777

1.25

4.57

1.8

1.5

—

Malignant neoplasm of larynx

4.25

4.54

1.5

1.7

—

Fracture of lower leg, including ankle

331

2566

1.28

4.53

1.5

1.6

—

Primary open-angle glaucoma

205

1451

1.37

4.52

1.7

1.5

—

Peritonsillar abscess

115

757

1.52

4.51

1.7

1.5

—

Other bacterial agents as the cause of diseases classified to other chapters

3.49

4.50

2.7

1.6

—

Small fibre neuropathy

105

2.51

4.49

2.3

1.9

—

Arthropathic psoriasis

431

1.70

4.49

1.3

1.7

—

Atrial septal defect

221

2.01

4.45

1.5

2.0

—

Specific personality disorders

124

832

1.50

4.44

1.5

1.7

—

Acquired absence of organs, not elsewhere classified

4.16

4.44

2.4

1.8

—

Erectile dysfunction

373

1.76

4.44

1.5

1.7

—

Open wound of forearm

358

1.77

4.43

1.8

1.7

—

Myopia

448

1.68

4.41

2.0

1.7

—

Malignant neoplasm of oral cavity

2.64

4.40

1.5

1.6

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

7.80

4.40

1.7

1.3

—

Colonic or urogenital fistula

163

1155

1.42

4.40

1.5

1.6

—

Primary open-angle glaucoma, strict

173

1236

1.40

4.40

1.7

1.5

—

Use of biperiden

183

2.10

4.37

1.4

1.9

—

Abscess of anal and rectal regions

323

1.81

4.37

1.4

1.6

—

Total colectomy

157

2.19

4.35

2.3

1.8

—

Total colectomy operation

157

2.19

4.35

2.3

1.8

—

Vitamin deficiency

157

2.19

4.35

2.6

1.7

—

Vitamin deficiency, wide

157

2.19

4.35

2.6

1.7

—

Disorders of pituitary gland, other and/or unspecified

6.49

4.34

1.2

1.3

—

Paralytic ileus

138

2.27

4.33

1.5

1.6

—

Malignant neoplasm of bladder, including Hilmo

410

1.71

4.33

1.6

1.5

—

Polyarthritis, unspecified

113

2.42

4.32

1.7

—

Panhypopituitarism

3.00

4.31

1.2

1.8

—

Nonalcoholic fatty liver disease

347

1.77

4.29

1.3

1.7

—

Combined immunodeficiencies

4.60

4.28

2.5

1.6

—

Infections with a predominantly sexual mode of transmission

150

1051

1.43

4.28

1.9

1.6

—

Other leukaemias of specified cell type

7.54

4.27

2.9

1.4

—

Ocular pain

282

1.86

4.27

1.8

1.7

—

Redundant prepuce, phimosis and paraphimosis

133

904

1.46

4.27

1.8

1.6

—

Intestinal adhesions without obstruction

326

1.79

4.25

1.3

1.5

—

Unspecified jaundice

152

2.19

4.25

1.3

1.7

—

Other and unspecified erythematous conditions

108

2.44

4.24

1.6

1.8

—

Pain and other conditions associated with female genital organs and menstrual cycle

572

1.56

4.24

1.4

1.6

—

Other forms of systemic lupus erythematosus

4.95

4.23

1.3

1.4

—

Mesothelioma

4.93

4.22

1.5

1.4

—

L02BX Other hormone antagonists and related agents

234

1.95

4.22

1.4

1.7

—

Other and unspecified glaucoma

262

1.89

4.21

1.3

1.5

—

Other specified and unspecified personality disorders

305

1.81

4.21

1.6

1.7

—

Other noninfective disorders of lymphatic vessels and lymph nodes

127

2.31

4.21

1.9

1.6

—

Kyphosis

3.48

4.21

1.4

1.8

—

Alcohol abuse, main dg

634

1.55

4.19

1.4

1.7

—

Psoriasis vulgaris

114

763

1.50

4.17

1.6

—

Injuries to the wrist and hand

628

3661

1.19

4.17

1.7

1.6

—

Astigmatism

263

1.88

4.15

2.0

1.9

—

Abdominal aortic aneurysm (AAA)

407

1.69

4.15

1.5

1.6

—

Certain conditions originating in the perinatal period

336

1.73

4.14

2.2

1.7

—

Hypoglycaemia, other or unspecified

278

1.85

4.14

1.8

—

Postmenopausal osteoporosis with pathological fracture

236

1.92

4.12

1.5

1.4

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

3.12

4.10

2.1

1.6

—

Acute gastritis

279

1.84

4.10

1.9

1.5

—

Biguanides

579

2949

1.20

4.09

1.5

1.6

—

Monocytic leukaemia

6.85

4.06

1.2

1.6

—

Any event in hilmo or specialist outpatient

+∞

4.06

1.2

0.0

—

Hyperhidrosis

3.22

4.06

1.3

1.4

—

Inflammatory diseases of prostate (prostatitis)

584

1.57

4.06

1.4

1.6

—

Membranous nephropathy

6.77

4.05

2.3

1.4

—

Malignant neoplasm of oropharynx, including Hilmo

10.35

4.04

2.1

1.0

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

4.01

4.04

1.9

—

Carbimazole or st.post thyroidectomy, condition for graves disease

115

777

1.49

4.03

1.5

1.6

—

Monoarthritis, not elsewhere classified

136

2.23

4.03

1.2

1.8

—

Other congenital malformations

369

1.72

4.02

2.1

1.9

—

Benign neoplasm of other and ill-defined parts of digestive system

112

754

1.49

4.01

1.7

1.5

—

Crossbite

293

1.78

3.99

2.1

1.8

—

Biological medicines for asthma

2.86

3.98

1.4

1.9

—

Delayed milestone in childhood

165

2.07

3.96

2.4

2.0

—

Ulcer of oesophagus

275

1.83

3.96

2.0

1.5

—

Chronic viral hepatitis

184

2.03

3.94

1.2

1.9

—

Other bacterial agents as the cause of diseases classified to other chapters

3.89

3.93

2.9

1.7

—

Collapsed vertebra, not elsewhere classified

4.93

3.91

1.5

1.7

—

Other misadventures during surgical and medical care

2.60

3.91

1.6

1.8

—

Scarlet fever

4.90

3.90

1.9

1.6

—

Hepatocellular carcinoma, including Hilmo

2.59

3.90

1.8

1.6

—

Drug-induced gout

5.54

3.89

1.6

1.4

—

Fall on same level involving ice and snow

340

2727

1.25

3.89

1.6

—

Chronic respiratory disease originating in the perinatal period

4.62

3.87

1.7

1.9

—

Malignant neoplasm of tongue

3.01

3.87

1.8

1.6

—

Sequelae of injuries of lower limb

344

1.73

3.85

1.2

1.8

—

Persistent mood disorders

106

712

1.49

3.84

1.9

1.6

—

Malignant neoplasm of base of tongue, including Hilmo

6.14

3.84

2.1

1.8

—

Malignant neoplasm of oesophagus

2.71

3.84

1.4

1.7

—

Personal history of malignant neoplasm

179

2.02

3.84

1.7

1.5

—

Degeneration of macula and posterior pole

303

1906

1.27

3.82

1.4

1.5

—

Other specified/unspecified spondylopathies

2.51

3.82

1.8

1.7

—

Impetigo

173

2.04

3.80

2.2

1.8

—

Respiratory tuberculosis, clinically confirmed

3.24

3.80

2.4

1.5

—

Mixed specific developmental disorders

141

2.14

3.79

1.9

1.7

—

Enteropathic arthropathies

2.76

3.77

1.4

1.7

—

Other benign neoplasms of skin

226

1732

1.31

3.76

1.7

1.5

—

Carcinoma in situ of skin of lower limb, including hip

2.68

3.75

1.9

1.5

—

Family history of malignant neoplasm

280

1.79

3.74

1.4

1.5

—

Polymyalgia rheumatica

564

1.55

3.74

1.4

1.5

—

Migraine without aura and triptan purchases

485

1.59

3.74

1.8

1.7

—

Cutaneous lupus erythematosus

2.60

3.73

1.2

1.6

—

Personal history of medical treatment

4.24

3.73

2.1

2.0

—

Mouth breathing

254

1977

1.29

3.72

2.0

1.7

—

Lifestyle-related condition

3.91

3.72

1.5

1.6

—

193

1.96

3.72

1.9

—

Post-traumatic stress disorder

216

1.91

3.72

2.0

1.8

—

Other factor of the environment

3.90

3.72

1.5

—

Other specified/unspecified bacterial intestinal infections

245

1.85

3.71

1.8

1.6

—

Other/unspecified mastoiditis and related conditions

5.85

3.70

1.6

1.4

—

Stomatitis and related lesions

120

833

1.45

3.70

2.1

1.6

—

Myocardial infarction, with ST-elevation

118

817

1.45

3.69

1.6

1.5

—

Ductal carcinoma of pancreas

5.79

3.69

1.1

1.3

—

Erythema multiforme

2.64

3.66

2.9

1.6

—

Leiomyosarcoma, including Hilmo

4.51

3.65

1.6

1.2

—

Disorders of vitreous body and globe

306

2347

1.25

3.65

1.7

1.6

—

Malignant neoplasm of rectum

283

1.78

3.63

1.4

1.5

—

Congenital malformations of trachea and bronchus

3.03

3.62

1.9

1.5

—

Other disorders of conjunctiva

577

1.53

3.61

2.1

1.6

—

Syndrome of inappropriate secretion of antidiuretic hormone

4.96

3.61

1.3

1.4

—

Ovarian cyst

182

775

1.36

3.60

1.5

1.6

—

Universal erythroderma, KELA reimbursement

3.00

3.60

1.5

1.7

—

Actinomycosis

8.10

3.60

1.6

1.2

—

Acute appendicitis

409

3152

1.21

3.59

1.6

—

Other mycoses, not elsewhere classified/unspecified

2.99

3.59

1.9

1.5

—

Degeneration of the brain due to alcohol

2.61

3.57

1.1

2.2

—

Enterohaemorrhagic Escherichia coli infection

10.81

3.57

1.5

1.2

—

Umbilical hernia

167

1236

1.36

3.56

1.6

—

Infarction of spleen

4.39

3.55

1.9

1.3

—

Colon adenocarcinoma

383

1.65

3.55

1.3

1.4

—

Drug-induced hypoglycaemia without coma

3.09

3.55

1.3

1.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

273

1.78

3.54

2.5

1.8

—

Giant cell arteritis

144

2.10

3.54

1.7

1.6

—

Scarlet fever

5.44

3.54

2.1

1.7

—

Fracture of skull and facial bones

124

874

1.42

3.54

1.4

1.6

—

Congenital stenosis of pulmonary valve

4.00

3.53

1.8

1.5

—

Calcific tendinitis of shoulder

192

1.94

3.53

1.6

1.8

—

Normotensive glaucoma

346

1.69

3.52

1.8

1.5

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

168

1247

1.35

3.51

1.5

1.6

—

Otitis externa

131

935

1.41

3.49

1.7

1.6

—

Radiculopathy

101

687

1.48

3.49

1.5

1.6

—

Pruritus

362

1.67

3.49

2.0

1.5

—

2.44

3.49

1.3

1.7

—

Chorioretinal inflammation

2.44

3.48

2.0

1.9

—

Adenocarcinoma of pancreas

2.64

3.48

1.3

1.6

—

Central retinal artery occlusion

2.57

3.48

1.3

1.7

—

Papilloedema, unspecified

2.50

3.48

2.3

1.6

—

Injury of intra-abdominal organs

2.50

3.48

1.4

1.5

—

Juvenile rheumatoid arthirtis

2.92

3.47

1.6

1.5

—

Disorders of vitreous body

295

2281

1.25

3.47

1.7

1.6

—

Anosmia

4.66

3.47

1.5

1.1

—

Strabismus

157

1153

1.36

3.46

1.7

1.6

—

Marginal zone B-cell lymphoma

4.66

3.46

1.4

1.9

—

Other disorders of pigmentation

146

2.07

3.42

2.4

1.6

—

Exposure to other specified factors

450

3454

1.20

3.42

1.7

1.6

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.61

3.40

1.7

1.8

—

Other and unspecified acne

3.14

3.39

1.3

1.9

—

Other predominantly sexually transmitted diseases, not elsewhere classified

634

1.49

3.39

2.1

1.6

—

Glaucoma suspect

214

1654

1.30

3.39

1.4

1.5

—

Disorders of adrenal gland, other and/or unspecified

5.92

3.38

1.3

1.2

—

Benign neoplasm: Tongue

101

2.31

3.38

1.5

1.7

—

Other female pelvic inflammatory diseases

530

1.53

3.37

1.5

—

Disorders of eyelid in diseases classified elsewhere

101

2.30

3.37

1.8

1.4

—

Malignant neoplasm of penis, including Hilmo

5.88

3.37

1.9

1.6

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

283

1.74

3.35

1.6

—

Other condition

571

1.51

3.35

1.8

1.7

—

Other/unspecified crystal arthropathies

4.50

3.35

1.9

1.3

—

Single ventricle heart

9.44

3.35

1.5

1.4

—

Nonspecific lymphadenitis

203

1.89

3.35

2.1

1.7

—

Intracranial nontraumatic haemorrhage of fetus and newborn

6.12

3.34

3.4

2.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.46

3.34

1.7

1.3

—

Malignant neoplasm of floor of mouth, including Hilmo

4.46

3.34

1.1

1.2

—

Myocardial infarction, unclassifiable

148

968

1.37

3.33

1.5

—

Calculus of kidney and ureter

187

1423

1.32

3.33

1.7

1.6

—

Nonpyogenic thrombosis of intracranial venous system

3.73

3.32

2.8

1.4

—

Nummular dermatitis

314

1.70

3.32

1.7

1.6

—

Toxic liver disease

2.96

3.32

1.6

1.8

—

Campylobacter enteritis

2.44

3.32

2.5

1.8

—

Degeneration of nervous system due to alcohol

2.50

3.31

1.1

2.1

—

Other conditions related to polyarteritis nodosa

9.07

3.31

1.8

1.6

—

Malignant neoplasm of stomach, including Hilmo

176

1.94

3.28

1.4

1.5

—

Maternal care for other conditions predominantly related to pregnancy

562

1.50

3.28

1.3

1.5

—

Diseases of appendix

436

3292

1.20

3.27

1.6

—

Other fall from one level to another

142

1040

1.37

3.26

1.5

1.6

—

Wet age-related macular degeneration

110

748

1.43

3.26

1.4

1.5

—

Other psoriatic arthropathies

385

1.62

3.25

1.3

1.7

—

Pustular psoriasis

163

1.98

3.25

1.6

1.7

—

Acute and transient psychotic disorders

424

1.59

3.25

1.8

1.7

—

Hypertrophy of breast

543

1.52

3.25

1.4

1.6

—

Pediculosis, acariasis and other infestations

227

1.82

3.24

2.1

1.9

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.58

3.24

1.9

1.5

—

Disorders of optic nerve, not elsewhere classified

2.54

3.23

1.7

—

Primary biliary cholangitis (PBC)

2.61

3.23

1.2

1.6

—

Actinomycosis

6.59

3.22

1.6

1.2

—

Urolithiasis

200

1544

1.30

3.22

1.6

—

Precocious central puberty

5.48

3.22

2.1

1.5

—

Malignant neoplasm of other and unspecified parts of biliary tract

3.59

3.21

1.6

1.4

—

Benign neoplasm: Pancreas

2.30

3.21

2.1

1.8

—

Secondary malignant neoplasm of respiratory and digestive organs

2.90

3.21

1.6

1.4

—

Other aneurysm

207

1.85

3.17

1.8

1.7

—

Complex cardiac defects

3.57

3.16

1.5

2.0

—

Necrotizing fasciitis

4.68

3.15

1.7

1.5

—

Paraplegia, diplegia of upper limbs

2.44

3.15

1.4

1.9

—

Pneumoconiosis due to asbestos and other mineral fibres

2.44

3.15

2.2

1.5

—

Unspecified contracted kidney

4.65

3.15

1.1

1.4

—

Scabies

165

1.96

3.15

2.0

—

Drug-induced systemic lupus erythematosus

4.63

3.14

1.1

1.3

—

Hypermetropia

304

1.69

3.13

1.6

1.8

—

Cryoglobulinemia

8.19

3.13

1.5

1.3

—

Nephropathy induced by other drugs, medicaments and biological substances

8.14

3.13

1.3

—

Other acute viral hepatitis

3.49

3.12

1.6

1.5

—

Rhabdomyosarcoma, including Hilmo

8.11

3.12

1.2

1.1

—

Juvenile arthritis (FINNGEN)

145

2.01

3.10

1.5

2.0

—

Fracture at wrist and hand level

197

1523

1.29

3.10

1.7

1.6

—

KRA_PSY_EATING, excluding more controls

179

1.90

3.09

1.9

1.7

—

Chronic myeloid leukaemia

7.73

3.08

1.0

1.3

—

Wilms' tumor, including Hilmo

5.15

3.08

1.5

1.3

—

Immunodeficiency associated with other major defects

6.19

3.08

5.4

1.5

—

Biliary cirrhosis, NAS

6.16

3.07

1.0

1.4

—

Other disorders of nervous system

261

1.74

3.07

1.7

—

Specific development disorders of speech and language

280

1.70

3.07

2.3

1.8

—

Hypertension, portal

6.13

3.07

1.3

1.5

—

Appendicitis, broad definition

430

3278

1.19

3.04

1.6

—

Neuroendocrine tumor and carcinoma of pancreas

5.99

3.04

1.3

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS